B0070 | | A1A, SERPINA1, AAT | Alpha-1-antitrypsin precursor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B0072 | | A1BG | Alpha-1B-glycoprotein precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 8 |
232462_s_at | | A1BG-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
A_24_P721699 | | A1BG-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0073 | | A1CF, ACF, ASP | APOBEC-1 stimulating protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0081 | | A2M, CPAMD5, FWP007 | Alpha-2-macroglobulin precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
1564139_at | | A2M-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0082 | | A2ML1, CPAMD9 | Alpha-2-Macroglobulin-like protein 1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B3450 | | A-362G6.2 | Hypothetical protein | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0087 | | A4GNT, alpha4GnT | Alpha-1,4-N-acetylglucosaminyltransferase | Blood | MS (Multiple sclerosis) | 1 |
BJ440 | | A7322, ARFGEF3, BIG3 | Brefeldin A-inhibited guanine nucleotide-exchange protein 3 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0094 | | AAAS, ADRACALA, GL003 | Aladin | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0096 | | AACS, ACSF1, SUR5 | Acetoacetyl-CoA synthetase | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0370 | | AADACL2 | Arylacetamide deacetylase-like protein 2 | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0098 | | AADAT, KAT2 | L-kynurenine/alpha-aminoadipate aminotransferase, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0099 | | AAED1 | Thioredoxin-like protein AAED1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0100 | | AAGAB | Alpha- and gamma-adaptin-binding protein P34 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0101 | | AAK1 | AP2 associated kinase 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(relapsing-remitting_MS), RRMS_SPMS (Multiple sclerosis) | 9 |
B0107 | | AAMDC, PTD015 | Mth938 domain-containing protein | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0108 | | AAMP | Angio-associated migratory cell protein | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0111 | | AAR2, CGI-23, PRO0225 | Protein AAR2 homolog | Blood | MS (Multiple sclerosis) | 1 |
BF871 | | AARS | Alanyl-tRNA synthetase | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
BF872 | | AARS2, AARSL | Probable alanyl-tRNA synthetase, mitochondrial precursor | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BK021 | | AARSD1, PTGES3L, PTGES3L-AARSD1 | Alanyl-tRNA editing protein Aarsd1 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0288 | | AASDH, ACSF4, U26 | Acyl-CoA synthetase family member 4 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
BJ403 | | AASDHPPT, CGI-80, HAH-P | Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0114 | | AASS, LKR/SDH | Alpha-aminoadipate semialdehyde synthase, mitochondrial | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0117 | | AATF, CHE1, DED | Apoptosis antagonizing transcription factor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B8967 | | AATK, AATYK, LMR1 | Serine/threonine-protein kinase LMTK1 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BJ595 | | ABAT, GABAT | 4-aminobutyrate aminotransferase, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0131 | | ABC-1, ABCA1, ABC1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
BJ394 | | ABCA10 | ATP-binding cassette sub-family A member 10 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0141 | | ABCA12, ABC12 | ATP-binding cassette transporter family A member 12 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 2 |
B0142 | | ABCA13 | ABC A13 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1A08 | | ABCA17P | Putative uncharacterized protein ABCA17P | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B0132 | | ABCA2, ABC2 | ATP-binding cassette, sub-family A, member 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0133 | | ABCA3, ABCA3 variant protein, ABC3 | ATP-binding cassette, sub-family A, member 3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0135 | | ABCA5 | ATP-binding cassette, sub-family A , member 5 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0136 | | ABCA6 | ABC transporter ABCA6 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0137 | | ABCA7, ABCA7/ABCA-SSN | ATP-binding cassette sub-family A member 7 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0138 | | ABCA8 | ATP-binding cassette, sub-family A, ABC1, member 8 | Blood | CIS (Multiple sclerosis) | 1 |
B0139 | | ABCA9 | ATP-binding cassette sub-family A member 9 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B9550 | | ABCB1, MDR1, PGY1 | Multidrug resistance protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 6 |
BJ395 | | ABCB10 | ATP-binding cassette, sub-family B, member 10, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B9551 | | ABCB4, MDR3, PGY3 | Multidrug resistance protein 3 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B0143 | | ABCB5 | ATP-binding cassette sub-family B member 5 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0144 | | ABCB6, MTABC3, PRP | ATP-binding cassette half-transporter | Blood | RRMS_SPMS (Multiple sclerosis) | 3 |
B0145 | | ABCB7, ABC7 | ATP-binding cassette, sub-family B, member 7, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0146 | | ABCB8, MABC1, ACCN3 | ATP-binding cassette, sub-family B, member 8, mitochondrial precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B9982 | | ABCC1, MRP, MRP1 | Multidrug resistance-associated protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B9988 | | ABCC10, MRP7, SIMRP7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0151 | | ABCC11, MRP8 | ATP-binding cassette transporter sub-family C member 11 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B9989 | | ABCC12, MRP9 | Multidrug resistance-associated protein 9 | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 1 |
B0152 | | ABCC13, PRED6 | ATP-binding cassette transporter C13 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 5 |
B9983 | | ABCC2, CMOAT, CMOAT1 | Canalicular multispecific organic anion transporter 1 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B9984 | | ABCC3, MRP3, CMOAT2 | ATP-binding cassette, sub-family C, member 3 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 13 |
B9986 | | ABCC5, MRP5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 3 |
B9987 | | ABCC6, ara, URG7 | Multidrug resistance-associated protein 6 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0149 | | ABCC8, SUR1, SUR | Sulfonylurea receptor 1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0150 | | ABCC9, SUR2 | Sulfonylurea receptor 2 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 5 |
B0154 | | ABCD2, ALD1, ALDL1 | ATP-binding cassette, sub-family D, member 2 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0155 | | ABCD3, PMP70, PXMP1 | ATP-binding cassette, sub-family D, member 3 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0156 | | ABCD4, PXMP1L | ATP-binding cassette, sub-family D, member 4 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0157 | | ABCE1, RLI, RNASEL1 | ATP-binding cassette sub-family E member 1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 6 |
B0158 | | ABCF1, ABC50 | ATP-binding cassette sub-family F (GCN20) member 1 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
BJ396 | | ABCF2, HUSSY-18 | ATP-binding cassette, sub-family F, member 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0159 | | ABCF3 | ATP-binding cassette sub-family F member 3 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0160 | | ABCG1, ABC8, WHT1 | ATP-binding cassette, sub-family G, member 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 13 |
B0161 | | ABCG2, ABCP, BCRP | ATP-binding cassette, sub-family G, member 2 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0162 | | ABCG4, WHITE2 | ATP-binding cassette, sub-family G, member 4 | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0163 | | ABCG5 | ATP-binding cassette, sub-family G, member 5 | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0164 | | ABCG8 | ATP-binding cassette, sub-family G, member 8 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0134 | | ABCR, ABCA4 | Retinal-specific ATP-binding cassette transporter | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 2 |
B0170 | | ABHD1, LABH1 | Lung alpha/beta hydrolase protein 1 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0177 | | ABHD10 | Abhydrolase domain-containing protein 10, mitochondrial precursor | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0178 | | ABHD11, WBSCR21, PP1226 | Abhydrolase domain-containing protein 11 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 5 |
B0165 | | ABHD12 | Abhydrolase domain-containing protein 12 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 4 |
B0119 | | ABHD12B | Abhydrolase domain-containing protein 12B | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0179 | | ABHD13 | Abhydrolase domain containing protein 13 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0180 | | ABHD14A, UNQ1913/PRO4373, SRSQ1913 | Alpha/beta hydrolase domain-containing protein 14A | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_3_month_follow-up) (Multiple sclerosis) | 6 |
B0181 | | ABHD14B, CIB | Alpha/beta hydrolase domain-containing protein 14B | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0169 | | ABHD15, UNQ6510/PRO21435, PPWG6510 | Abhydrolase domain containing protein 15 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0183 | | ABHD16B | Hypothetical protein C20orf135 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0120 | | ABHD17A, FAM108A1 | Alpha/beta hydrolase domain-containing protein 17A | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0121 | | ABHD17B, FAM108B1, CGI-67 | Alpha/beta hydrolase domain-containing protein 17B | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0122 | | ABHD17C, FAM108C1 | Alpha/beta hydrolase domain-containing protein 17C | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0171 | | ABHD2, LABH2 | Abhydrolase domain containing protein 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 18 |
B0172 | | ABHD3, LABH3 | Abhydrolase domain-containing protein 3 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0173 | | ABHD4 | Abhydrolase domain-containing protein 4 | Blood | RRMS_(CD8+), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0174 | | ABHD5, NCIE2, CGI-58 | 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 | Blood | RRMS_(High_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B0175 | | ABHD6 | Monoacylglycerol lipase ABHD6 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 16 |
B0184 | | ABI1, SSH3BP, SSH3BP1 | Spectrin SH3 binding protein | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0185 | | ABI2, ARGBPIA, ABI2B | Abl-interactor protein 2B | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 14 |
B0186 | | ABI3, NESH | ABI gene family member 3 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
BG144 | | ABI3BP, NESHBP, TARSH | Target of Nesh-SH3 precursor | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 2 |
B0187 | | ABL1, ABL, JTK7 | Proto-oncogene tyrosine-protein kinase ABL1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0188 | | ABL2, ABLL, ARG | Tyrosine-protein kinase ABL2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 5 |
B0189 | | ABLIM1, ABLIM, LIMAB1 | Actin-binding LIM protein 1 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0190 | | ABLIM2 | Actin-binding LIM protein 2 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0191 | | ABLIM3, HMFN1661 | Actin-binding LIM protein 3 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1483 | | ABO | Histo-blood group ABO system transferase | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0773 | | ABP1, AOC1, DAO1 | Amiloride-sensitive amine oxidase [copper-containing] precursor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0192 | | ABR | Active breakpoint cluster region-related protein | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0193 | | ABRA, STARS | Actin-binding RHO-activating protein | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B0195 | | ABT1, HABT1 | Basal transcriptional activator hABT1 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 2 |
B0196 | | ABTB1, BPOZ, PP2259 | Ankyrin repeat and BTB POZ domain containing protein 1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0197 | | ABTB2 | Ankyrin repeat and BTB/POZ domain-containing protein 2 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B7298 | | A-C1, HRASLS, HSD28 | Phospholipid-metabolizing enzyme A-C1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 6 |
BZ6GQ | | ACA59 | Small nucleolar RNA ACA59 | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
BZ3GP | | ACA64 | Small nucleolar RNA ACA64 | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
BZ8G8 | | ACA64 | Small nucleolar RNA ACA64 | Blood | RRMS_CIS_(IFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 1 |
BG484 | | ACAA1, ACAA, PTHIO | 3-ketoacyl-CoA thiolase, peroxisomal precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
BG486 | | ACAA2 | Acetyl-CoA acyltransferase 2 | Blood | PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 3 |
B0198 | | ACACA, ACAC, ACC1 | Acetyl-CoA carboxylase 1 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0199 | | ACACB, ACC2, ACCB | Acetyl-CoA carboxylase 2 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B0218 | | ACAD10 | Acyl-CoA dehydrohenase family member 10 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0219 | | ACAD11 | Acyl-CoA dehydrogenase family member 11 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
B0200 | | ACAD8, ARC42, IBD | Acyl-CoA dehydrogenase family member 8, mitochondrial precursor | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B0201 | | ACAD9 | Acyl-CoA dehydrogenase family member 9, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0202 | | ACADL | Acyl-CoA dehydrogenase, long-chain specific, mitochondrial precursor | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 3 |
B0203 | | ACADM, MCAD | Acyl-CoA dehydrogenase, medium-chain specific, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0204 | | ACADS | Acyl-CoA dehydrogenase, short-chain specific, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0220 | | ACADSB | Acyl-CoA dehydrogenase, short/branched chain specific, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0205 | | ACADVL, VLCAD | Acyl-CoA dehydrogenase, very-long-chain specific, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
BC210 | | ACAN, AGC1, CSPG1 | Aggrecan core protein precursor | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0206 | | ACAP1, CENTB1 | Centaurin beta 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0207 | | ACAP2, CENTB2 | ARF-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0208 | | ACAP3, CENTB5 | ARF-GAP with coiled-coil, ANK repeat and PH domain containing protein 3 | Blood | MS (Multiple sclerosis) | 1 |
BG485 | | ACAT1, ACAT, MAT | Acetyl-CoA acetyltransferase, mitochondrial precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
BG483 | | ACAT2, ACTL | Cytosolic acetoacetyl-coenzyme A thiolase | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
BJ598 | | ACBD3, GCP60, GOCAP1 | Golgi resident protein GCP60 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0210 | | ACBD4, HMFT0700 | Acyl-CoA-binding domain-containing protein 4 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0211 | | ACBD5 | Acyl-coenzyme A binding domain containing 5 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 10 |
B0212 | | ACBD6 | Acyl-CoA-binding domain-containing protein 6 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0213 | | ACBD7 | Acyl-CoA-binding domain-containing protein 7 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1099 | | ACCN2, ASIC1, BNAC2 | Amiloride-sensitive cation channel 2, neuronal | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1101 | | ACCN3, ASIC3, SLNAC1 | Amiloride-sensitive cation channel 3 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0007 | | ACCS, PHACS | 1-aminocyclopropane-1-carboxylate synthase-like protein 1 | Blood | CIS, RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0217 | | ACD, PIP1, PTOP | Adrenocortical dysplasia protein homolog | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0221 | | ACE, DCP, DCP1 | Angiotensin-converting enzyme, somatic isoform precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0222 | | ACE2, UNQ868/PRO1885, UNQ868 | Angiotensin-converting enzyme 2 precursor | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0223 | | ACER1, ASAH3 | Alkaline ceramidase 1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0225 | | ACER3, APHC, PHCA | Alkaline ceramidase 3 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B0226 | | ACHE, ARACHE | Acetylcholinesterase precursor | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B0243 | | ACIN1, ACINUS | Apoptotic chromatin condensation inducer 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0246 | | ACKR2, CCBP2, CCR10 | Atypical chemokine receptor 2 | Blood | RRMS_(relapsing-remitting_MS), RRMS_SPMS (Multiple sclerosis) | 2 |
B0247 | | ACKR3, CXCR7, CMKOR1 | Atypical chemokine receptor 3 | Blood | CIS, RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0248 | | ACKR4, CCRL1, CCBP2 | Atypical chemokine receptor 4 | Blood | CIS, MS (Multiple sclerosis) | 2 |
B0254 | | ACLY | ATP-citrate synthase | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0261 | | ACN9, DC11 | Protein ACN9 homolog, mitochondrial precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0266 | | ACO1, IRP1, IREB1 | Iron-responsive element binding protein 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
BJ398 | | ACO2 | Aconitate hydratase, mitochondrial precursor | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0267 | | ACOT1, CTE1 | Acyl-coenzyme A thioesterase 1 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0262 | | ACOT11, BFIT, THEA | Acyl-coenzyme A thioesterase 11 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0264 | | ACOT13, THEM2, HT012 | Acyl-coenzyme A thioesterase 13 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0268 | | ACOT2, PTE2, PTE2A | Peroxisomal acyl-coenzyme A thioester hydrolase 2a | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0269 | | ACOT4, PTE2B, PTEIB | Acyl-coenzyme A thioesterase 4 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B1362 | | ACOT7, BACH | Cytosolic acyl coenzyme A thioester hydrolase | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1365 | | ACOT7L, BACHL | Cytosolic acyl coenzyme A thioester hydrolase-like | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0271 | | ACOT8, ACTEIII, PTE1 | Acyl-CoA thioesterase 8 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0272 | | ACOT9, CGI-16, ACATE2 | Acyl-coenzyme A thioesterase 9, mitochondrial | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0273 | | ACOX1, ACOX | Acyl-coenzyme A oxidase 1, peroxisomal | Blood | CIS, RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0275 | | ACOX3, BRCOX, PRCOX | Acyl-coenzyme A oxidase 3, peroxisomal | Blood | MS (Multiple sclerosis) | 1 |
B0276 | | ACOXL | Acyl-coenzyme A oxidase-like protein 1 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 2 |
BC675 | | ACP1 | Red cell acid phosphatase 1, isozyme F/S | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
BC678 | | ACP2 | Lysosomal acid phosphatase precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BC673 | | ACP5 | Tartrate-resistant acid phosphatase type 5 precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BC674 | | ACP6, ACPL1, LPAP | Lysophosphatidic acid phosphatase type 6 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0278 | | ACPL2, UNQ370/PRO706, UNQ370 | Acid phosphatase-like protein 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BC679 | | ACPP | Prostatic acid phosphatase precursor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
BC683 | | ACPT | Acid phosphatase | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0280 | | ACRBP, SP32 | Acrosin binding protein | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 8 |
B0281 | | ACRC, NAAR1 | Acidic repeat-containing protein | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1123 | | ACRV1 | Acrosomal protein SP-10 precursor | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0214 | | ACSBG1, BGM, LPD | Very long-chain acyl-CoA synthetase, lipidosin | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0215 | | ACSBG2, BGR, UNQ2443/PRO5005 | Long-chian-fatty-acid--CoA ligase ACSBG2 | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0286 | | ACSF2, UNQ493/PRO1009, UNQ493 | Acyl-CoA synthetase family member 2, mitochondrial precursor | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0287 | | ACSF3 | Acyl-CoA synthetase family member 3, mitochondrial | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B0289 | | ACSL1, FACL1, FACL2 | Long-chain-fatty-acid--CoA ligase 1 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BJ400 | | ACSL3, ACS3, FACL3 | Long-chain-fatty-acid--CoA ligase 3 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0290 | | ACSL4, ACS4, FACL4 | Long-chain-fatty-acid--CoA ligase 4 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0291 | | ACSL5, ACS5, FACL5 | Long-chain-fatty-acid--CoA ligase 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0292 | | ACSL6, ACS2, FACL6 | Long-chain-fatty-acid--CoA ligase 6 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B0293 | | ACSM1, BUCS1, LAE | Acyl-coenzyme A synthetase ACSM1, mitochondrial | Blood | CIS, RRMS_(CD4+), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BJ399 | | ACSM2A, ACSM2, MACS2 | Acyl-CoA synthetase medium chain family member 2A | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
B0294 | | ACSM3, SAH, SA | Acyl-coenzyme A synthetase ACSM3, mitochondrial precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0296 | | ACSM5, MACS3 | Acyl-coenzyme A synthetase ACSM5, mitochondrial | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B0284 | | ACSS1, ACAS2L | Acetyl-coenzyme A synthetase 2-like, mitochondrial precursor | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B0285 | | ACSS2, ACAS2 | Acetyl-coenzyme A synthetase, cytoplasmic | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0298 | | ACSS3 | Acyl-CoA synthetase short-chain family member 3 mitochondrial | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
BO651 | | ACT | Pseudogene candidate | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B0312 | | ACTA1, ACTA | Actin, alpha skeletal muscle | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0299 | | ACTA2, ACTSA, ACTVS | Actin, aortic smooth muscle | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0300 | | ACTB, PS1TP5BP1 | Actin, cytoplasmic 1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 11 |
B0302 | | ACTC1, ACTC | Actin, alpha cardiac muscle 1 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B0303 | | ACTG1, ACTG | Actin, cytoplasmic 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 34 |
B0304 | | ACTG2, ACTA3, ACTL3 | Actin, gamma 2 propeptide | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0249 | | ACTL10 | Putative Uncharacterized actin family protein C20ORF134 | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0250 | | ACTL6A, BAF53, BAF53A | Actin-like protein 6A | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
B0251 | | ACTL6B, ACTL6, BAF53B | Actin-like protein 6B | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0252 | | ACTL7A | Actin-like-7-alpha | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0306 | | ACTL8 | Actin like protein 8 | Blood | MS (Multiple sclerosis) | 1 |
B0307 | | ACTL9, ACTL7C, HSD21 | Actin-like protein 9 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 3 |
B0308 | | ACTN1 | Alpha-actinin 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0309 | | ACTN2 | Alpha-actinin 2 | Blood | MS (Multiple sclerosis) | 1 |
B0310 | | ACTN3 | Alpha-actinin 3 | Blood | MS (Multiple sclerosis) | 1 |
B0311 | | ACTN4 | Alpha-actinin 4 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1015 | | ACTR10, ACTR11, ARP11 | Actin-related protein 10 | Blood | MS (Multiple sclerosis) | 1 |
B0317 | | ACTR1A, CTRN1 | Alpha-centractin | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0316 | | ACTR1B, CTRN2, ARP1 | Beta-centractin | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B1017 | | ACTR2, ARP2 | Actin-like protein 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 14 |
B1019 | | ACTR3, ARP3 | Actin-like protein 3 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B1020 | | ACTR3B, ARP4, ARP3BETA | Actin-related protein 3B | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BJ424 | | ACTR3C, ARP11 | Actin-related protein 3C | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1021 | | ACTR5, ARP5, NY-SAR-16 | Actin-related protein 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1023 | | ACTR6, CDA12, MSTP136 | Actin-related protein 6 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1024 | | ACTR8, ARP8, INO80N | Actin-related protein 8 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0314 | | ACTRT2, ARPM2, HARPM2 | Actin-related protein T2/M2/hArpM2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 3 |
B0315 | | ACTRT3, ARPM1 | Actin related protein M1 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 2 |
B0321 | | ACVR1, ACVRLK2 | Activin receptor type 1 precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0318 | | ACVR1B, ACVRLK4, ALK4 | Activin receptor type-1B | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0319 | | ACVR1C, ALK7 | Activin receptor type-1C | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1296 | | ACVR2A, ACVR2 | Activin receptor type-2A | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B1297 | | ACVR2B | Activin receptor type IIB precursor | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0320 | | ACVRL1, ACVRLK1, ALK1 | Serine/threonine-protein kinase receptor R3 precursor | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0325 | | ACYP1, ACYPE | Acylphosphatase, organ-common type isozyme | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0326 | | ACYP2, ACYP | Acylphosphatase 2, muscle type isozyme | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B5136 | | AD-011, HSPC288, x0006 | Probable Ergosterol biosynthetic protein 28 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BJ570 | | AD021, FAM198B, ENED | Protein ENED | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0327 | | ADA, ADA1 | Adenosine deaminase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0350 | | ADAD1, TENR, Tenr | Adenosine deaminase domain-containing protein 1 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0351 | | ADAD2, TENRL | Adenosine deaminase domain-containing protein 2 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 2 |
B0352 | | ADAL | Adenosine deaminase-like protein | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B0328 | | ADAM10, KUZ, MADM | ADAM 10 precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0329 | | ADAM11, MDC | ADAM 11 precursor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0330 | | ADAM12, MLTN, UNQ346/PRO545 | ADAM 12 precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0331 | | ADAM15, MDC15 | A disintegrin and metalloproteinase domain 15 precursor | Blood | RRMS_(CD8+) (Multiple sclerosis) | 3 |
B0332 | | ADAM17, CSVP, TACE | ADAM 17 precursor | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0333 | | ADAM18, TMDC3, UNQ858/PRO1867 | ADAM 18 precursor | Blood | CIS, RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0334 | | ADAM19, MLTNB, FKSG34 | ADAM 19 precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0353 | | ADAM2, FTNB | ADAM 2 precursor | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0338 | | ADAM20 | ADAM 20 precursor | Blood | CIS (Multiple sclerosis) | 1 |
B0340 | | ADAM22, MDC2 | ADAM 22 precursor | Blood | CIS, RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 15 |
B0341 | | ADAM23, MDC3 | ADAM 23 precursor | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0342 | | ADAM28, ADAM23, MDCL | ADAM 28 precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0347 | | ADAM30, UNQ2509/PRO5997, UNQ2509 | ADAM 30 precursor | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0348 | | ADAM32, UNQ5982/PRO21340 | A Disintegrin And Metalloproteinase domain-containing protein 32 | Blood | CIS, RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BL447 | | ADAM3B, CYRN2 | Cyritestin 2 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0355 | | ADAM7, GP83 | Disintegrin and metalloproteinase domain-containing protein 7 | Blood | CIS, RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B0356 | | ADAM8, MS2 | ADAM 8 precursor | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0357 | | ADAM9, MCMP, MDC9 | ADAM 9 precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 6 |
B0386 | | ADAMDEC1 | ADAM-like, Decysin 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1255 | | ADAMTS1, METH1 | ADAMTS-1 precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B1256 | | ADAMTS10 | ADAMTS-10 precursor | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B1257 | | ADAMTS12, UNQ1918/PRO4389, UNQ1918 | ADAM metallopeptidase with thrombospondin type 1 motif, 1, preproprotein | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1258 | | ADAMTS13, UNQ6102/PRO20085, vWF-CP | A disintegrin-like and metalloprotease (Reprolysin type) with thrombospondin type 1 motif, 13 preproprotein | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B1259 | | ADAMTS14 | ADAMTS-14 precursor | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1260 | | ADAMTS15 | ADAMTS-15 precursor | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B1264 | | ADAMTS19 | A disintegrin and metalloproteinase with thrombospondin motifs 19 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
B1265 | | ADAMTS2, PCINP, PCPNI | ADAMTS-2 precursor | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1266 | | ADAMTS20 | A disintegrin and metalloproteinase with thrombospondin motifs 20 | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B1267 | | ADAMTS3 | A disintegrin and metalloproteinase with thrombospondin motifs 3 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1268 | | ADAMTS4, UNQ769/PRO1563, UNQ769 | A disintegrin and metalloproteinase with thrombospondin motifs 4 | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1269 | | ADAMTS5, ADAMTS11, ADMP2 | A disintegrin and metalloproteinase with thrombospondin motifs 5 | Blood | CIS, RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 14 |
B1270 | | ADAMTS6 | ADAMTS-6 precursor | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B1271 | | ADAMTS7 | ADAM metallopeptidase with Thrombospondin type 1 motif, 7, preproprotein | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B1272 | | ADAMTS8, METH2 | ADAMTS-8 precursor | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B1273 | | ADAMTS9 | ADAMTS-9 precursor | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
241369_at | | ADAMTS9-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
1556364_at | | ADAMTS9-AS2 | unspecified molecule w/o gene mapping | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
A_24_P756494 | | ADAMTS9-AS2 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 3 |
B1213 | | ADAMTSL1, ADAMTSR1, UNQ528/PRO1071 | ADAMTS-like protein 1 precursor | Blood | CIS, RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1214 | | ADAMTSL2 | ADAMTS-like protein 2 precursor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B1216 | | ADAMTSL4, TSRC1, PP1396 | ADAMTS-like protein 4 precursor | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BM058 | | ADAMTSL4 | Hypothetical protein | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1217 | | ADAMTSL5, THSD6 | Thrombospondin, type I domain containing protein 6 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0358 | | ADAP1, CENTA1 | Centaurin, alpha 1 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B4650 | | ADAR, ADAR1, DSRAD | Double-stranded RNA-specific adenosine deaminase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
BJ830 | | ADARB1, hRED1, ADAR2d | RNA-specific adenosine deaminase B1 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
BD504 | | ADARB2, ADAR3, RED2 | Adenosine deaminase, RNA-specific, B2 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0361 | | ADARB2-AS1 | Putative uncharacterized protein ADARB2-AS1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0362 | | ADAT1, HADAT1 | tRNA-specific adenosine deaminase 1 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0363 | | ADAT2, DEADC1 | tRNA-specific adenosine deaminase 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0364 | | ADC, ODCP, ODC-p | Ornithine decarboxylase-like protein | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0366 | | ADCK2, AARF | aarF domain containing kinase 2 | Blood | CIS, RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0368 | | ADCK4 | Uncharacterized AARF domain-containing protein kinase 4 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0369 | | ADCK5 | aarF domain containing kinase 5 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0373 | | ADCY1 | Adenylate cyclase, type 1 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 2 |
B0382 | | ADCY10, SAC | Adenylate cyclase type 10 | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
BK280 | | ADCY10P1 | Similar to Soluble adenylyl cyclase | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 6 |
B0374 | | ADCY2 | Adenylate cyclase 2 | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B0375 | | ADCY3 | Adenylate cyclase type 3 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B0376 | | ADCY4 | Adenylate cyclase 4 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
B0377 | | ADCY5 | Adenylate cyclase 5 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0378 | | ADCY6 | Adenylate cyclase type 6 | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0379 | | ADCY7 | Adenylate cyclase, type VII | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0380 | | ADCY8 | Adenylate cyclase, type VIII | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B0381 | | ADCY9 | Adenylate cyclase type 9 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BB791 | | ADCYAP1R1 | Pituitary adenylate cyclase activating polypeptide type I receptor precursor | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0383 | | ADD1, ADDA | Alpha adducin | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0384 | | ADD2, ADDB | Beta adducin | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 16 |
B0385 | | ADD3, ADDL | Gamma adducin | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
BC494 | | ADFP, PLIN2 | Adipophilin | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0387 | | ADGB, CAPN7L | Calpain-7-like protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0388 | | ADH1A, ADH1 | Alcohol dehydrogenase 1A | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0389 | | ADH1B, ADH2 | Alcohol dehydrogenase beta chain | Blood | RRMS_(High_Sema4A), RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0390 | | ADH3, ADH1C | Alcohol dehydrogenase 1C | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 2 |
B0391 | | ADH4 | Alcohol dehydrogenase 4 | Blood | CIS, RRMS_(CD8+) (Multiple sclerosis) | 5 |
B0392 | | ADH5, ADH6 | Alcohol dehydrogenase 6 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0394 | | ADH5, ADHX, FDH | Alcohol dehydrogenase class III chi chain | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0393 | | ADH7 | Alcohol dehydrogenase class IV mu/sigma chain | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B7265 | | ADHFE1, HMFT2263 | Hydroxyacid-oxoacid transdehydrogenase, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BA102 | | ADI1, MTCBP1, HMFT1638 | 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0395 | | ADIG, SMAF1 | Small adipocyte factor 1 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0397 | | ADIPOQ, ACDC, ACRP30 | Adiponectin precursor | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 4 |
B0408 | | ADIPOR1, PAQR1, TESBP1A | Adiponectin receptor protein 1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0409 | | ADIPOR2, PAQR2 | Adiponectin receptor protein 2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0398 | | ADIRF, APM2, AFRO | Adipose most abundant gene transcript 2 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
232300_at | | ADIRF-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0399 | | ADK | Adenosine kinase | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0402 | | ADM, AM | ADM precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0400 | | ADM2, AM2 | Intermedin | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 2 |
B0401 | | ADM5 | PREDICTED: Hypothetical protein XP_373810 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0403 | | ADNP, ADNP1 | Activity-dependent neuroprotector | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0404 | | ADNP2, ZNF508, NT2RM4001810 | ADNP homeobox protein 2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0425 | | ADO | 2-aminoethanethiol dioxygenase | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0089 | | ADORA1 | Adenosine A1 receptor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0090 | | ADORA2A, ADORA2, HA2AR | Adenosine A2a receptor | Blood | CIS, RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0113 | | ADORA2A-AS1 | Putative uncharacterized protein ADORA2A-AS1 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0091 | | ADORA2B | Adenosine A2b receptor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
BK020 | | ADORA3, UNQ1931/PRO4406, UNQ1931 | Adenosine A3 receptor | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0405 | | ADPGK, RbBP-35 | ADP-dependent glucokinase | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0406 | | ADPRH, ARH1 | [Protein ADP-ribosylarginine] hydrolase | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0956 | | ADPRHL1, ARH2 | [Protein ADP-ribosylarginine] hydrolase-like protein 1 | Blood | CIS, MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0957 | | ADPRHL2, ARH3 | Poly (ADP-ribose) glycohydrolaseE ARH | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0407 | | ADPRM, MDS006, NBLA03831 | Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0336 | | ADRA1B | Alpha-1B adrenergic receptor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B0335 | | ADRA1C, ADRA1A | Alpha-1A adrenergic receptor | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0337 | | ADRA1D, ADRA1A | Alpha-1D adrenergic receptor | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B0344 | | ADRA2A, ADRA2R, ADRAR | Alpha-2A adrenergic receptor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0345 | | ADRA2B, ADRA2L1, ADRA2RL1 | Alpha-2B adrenergic receptor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0346 | | ADRA2C, ADRA2L2, ADRA2RL2 | Alpha-2C-adrenergic receptor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0410 | | ADRB1, ADRB1R, B1AR | Beta-1 adrenergic receptor | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0411 | | ADRB2, ADRB2R, B2AR | Beta-2 adrenergic receptor | Blood | CIS, RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0906 | | ADRBK1, BARK, BARK1 | Beta-adrenergic receptor kinase 1 | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
B0907 | | ADRBK2, BARK2, GRK3 | Beta-adrenergic receptor kinase 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B0413 | | ADRM1, GP110 | Proteasomal ubiquitin receptor ADRM1 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
BD139 | | ADSL, AMPS | Adenylosuccinate lyase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
BD143 | | ADSS, ADSS2 | Adenylosuccinate synthetase 2 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BD142 | | ADSSL1, ADSS1 | Adenylosuccinate synthetase isozyme 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0420 | | ADTRP | Uncharacterized protein C6ORF105 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0423 | | AEBP1, ACLP | Adipocyte enhancer-binding protein 1 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0424 | | AEBP2 | Zinc finger protein AEBP2 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B0427 | | AEN, pp12744, ISG20L1 | Apoptosis-enhancing nuclease | Blood | MS (Multiple sclerosis) | 1 |
BJ404 | | AES, GRG | GRG protein | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0428 | | AF10, MLLT10, MLL/AF10 fusion | AF-10 protein | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 16 |
B0431 | | AF1Q, MLLT11 | Protein AF1q | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0434 | | AFAP1, AFAP | Actin filament associated protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1Y67 | | AFAP1-AS1 | Similar to actin filament associated protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 5 |
B0429 | | AFAP1L1 | Actin filament-associated protein 1-like 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0430 | | AFAP1L2, XB130 | Actin filament-associated protein 1-like 2 | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
BM653 | | AFARP1 | AFARP1 protein | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0435 | | AFF1, AF-4, MLLT2 | AF4/FMR2 family member 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 7 |
B0436 | | AFF2, FMR2, OX19 | Fragile X mental retardation 2 protein | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0437 | | AFF3, LAF4 | AF4/FMR2 family member 3 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
BJ407 | | AFF4, AF5Q31, MCEF | AF5q31 protein | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 18 |
BO296 | | AFG3L1-locus | Hypothetical protein | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0438 | | AFG3L2 | AFG3-like protein 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0433 | | AFM, ALB2, ALBA | Afamin precursor | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B8328 | | AFMID | Probable Arylformamidase | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B5769 | | AFP, HPAFP | Alpha-fetoprotein precursor | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
BJ408 | | AFTPH, AFTH | Aftiphilin | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
B2974 | | AG2 | PREDICTED: Hypothetical protein XP_373497 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1115 | | AGA, GA | N(4)-(beta)-N-acetylglucosaminyl-L-asparaginase precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0444 | | AGAP1, CENTG2 | Centaurin gamma 2 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0442 | | AGAP10, BMS1P2, CTGLF7 | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10 | Blood | CIS, MS, RRMS_SPMS, RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 10 |
B0445 | | AGAP2, CENTG1 | ARF-GAP with GTPase, ANK repeat and PH domain-containing protein 2 | Blood | RRMS_(CD4+), RRMS_(CD8+), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BN535 | | AGAP2-AS1 | HCG2014417, isoform CRA_a | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0446 | | AGAP3, CENTG3, MRIP-1 | Centaurin gamma 3 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B0447 | | AGAP4, CTGLF1, MRIP2 | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0449 | | AGAP7, CTGLF4 | ARF-GAP with GTPase, ANK repeat and PH domain-containing protein 7 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B2077 | | AGBL1, CCP4 | Cytosolic carboxypeptidase 4 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B2075 | | AGBL2, CCP2 | Cytosolic carboxypeptidase 2 | Blood | MS (Multiple sclerosis) | 1 |
B2076 | | AGBL3, CCP3 | Cytosolic carboxypeptidase 3 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B2079 | | AGBL4, CCP6 | Cytosolic carboxypeptidase 6 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 2 |
B2078 | | AGBL5, CCP5 | Cytosolic carboxypeptidase-like protein 5 | Blood | CIS, RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
BD310 | | AGER, RAGE | Advanced glycosylation end product-specific receptor precursor | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0452 | | AGFG1, HRB, RAB | Nucleoporin-like protein RIP | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 13 |
B0454 | | AGGF1, GPATC7, GPATCH7 | Angiogenic factor with G patch and FHA domains 1 | Blood | MS, RRMS_SPMS, PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 4 |
B0456 | | AGK, MULK | Acylglycerol kinase, mitochondrial precursor | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B6313 | | AGL, GDE | Glycogen debranching enzyme | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
BF430 | | AGMAT | Agmatinase, mitochondrial precursor | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BC458 | | AGPAT1, G15 | 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
BC459 | | AGPAT2 | 1-acyl-sn-glycerol-3-phosphate acyltransferase beta | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
BC464 | | AGPAT3, UNQ759/PRO1490, UNQ759 | 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 19 |
BC465 | | AGPAT4, UNQ499/PRO1016, UNQ499 | 1-acylglycerol-3-phosphate O- acyltransferase 4 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0455 | | AGPAT4-IT1 | Putative uncharacterized protein encoded by AGPAT4-IT1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BC469 | | AGPAT5, LPAAT-e | 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B6650 | | AGPAT6, GPAT4, UNQ551/PRO1108 | Glycerol-3-phosphate acyltransferase 4 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B6649 | | AGPAT9, GPAT3, MAG1 | Glycerol-3-phosphate acyltransferase 3 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0360 | | AGPS, AAG5 | Alkyldihydroxyacetonephosphate synthase, peroxisomal precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 17 |
B0462 | | AGR2, AG2, UNQ515/PRO1030 | Secreted cement gland protein XAG-2 homolog | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B0464 | | AGRN, AGRIN | Agrin | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 21 |
B2918 | | AGRN | Hypothetical protein | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B0465 | | AgRP, AGRP, AGRT | Agouti-related protein precursor | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
BJ463 | | AGTPBP1, CCP1, NNA1 | Cytosolic carboxypeptidase 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0467 | | AGTR1, AGTR1A, AGTR1B | Type-1 angiotensin II receptor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1251 | | AGTRAP, ATRAP | Type-1 Angiotensin II receptor associated protein | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0466 | | AGXT2, AGT2 | Alanine--glyoxylate aminotransferase 2, mitochondrial precursor | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B4967 | | AHCTF1, ELYS, TMBS62 | ELYS transcription factor-like protein TMBS62 | Blood | CIS, RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
BE519 | | AHCY, SAHH | Adenosylhomocysteinase | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
BE520 | | AHCYL1, DCAL, XPVKONA | Adenosylhomocysteinase 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
BE521 | | AHCYL2 | S-Adenosylhomocysteine hydrolase-like 2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0469 | | AHDC1 | AT hook DNA-binding motif-containing protein 1 | Blood | CIS, MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0470 | | AHI-1, AHI1 | Jouberin | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 11 |
B0471 | | AHNAK, PM227 | Neuroblast differentiation associated protein AHNAK | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0472 | | AHNAK2 | Chromosome 14 open reading frame 78 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 2 |
B0473 | | AHR, BHLHE76 | Aryl hydrocarbon receptor precursor | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0475 | | AHSA1, HSPC322 | Activator of 90 kDa heat shock protein ATPase homolog 1 | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0476 | | AHSA2 | Activator of 90 kDa heat shock protein ATPase homolog 2 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 13 |
B5770 | | AHSG, FETUA, PRO2743 | Alpha-2-HS-glycoprotein precursor | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0478 | | AICDA, AID | Single-stranded DNA cytosine deaminase | Blood | RRMS_(High_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0479 | | AIDA | Axin interactor, dorsalization-associated protein | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0480 | | AIF1, G1, IBA1 | Allograft inflammatory factor-1 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0481 | | AIF1L, IBA2, UNQ672/PRO1306 | Allograft inflammatory factor-1 like | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 4 |
B0483 | | AIFM2, AMID, PRG3 | P53-responsive gene 3 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0484 | | AIFM3, AIFL | Apoptosis-inducing factor 3 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0485 | | AIG1, CGI-103, AIG-1 | Androgen-induced protein 1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0486 | | AIM1, CRYBG1 | Absent in melanoma 1 protein | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0487 | | AIM1L, CRYBG2 | Absent in melanoma 1-like protein | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BO596 | | AIM1L-locus | Absent in melanoma 1-like N-terminal extended | Blood | MS (Multiple sclerosis) | 1 |
B0488 | | AIM2 | Interferon-inducible protein AIM2 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0489 | | AIMP1, EMAP2, SCYE1 | Multisynthetase complex auxiliary component p43 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0490 | | AIMP2, JTV1, PRO0992 | Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B0492 | | AIP, XAP2 | AH receptor-interacting protein | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0493 | | AIPL1, AIPL2 | Aryl-hydrocarbon interacting protein-like 1 | Blood | MS (Multiple sclerosis) | 1 |
B0494 | | AIRE, APECED | Autoimmune regulator | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0495 | | AJAP1, MOT8, SHREW1 | Adherens junction-associated protein 1 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B8126 | | AK1 | Adenylate kinase isoenzyme 1 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B8127 | | AK2, ADK2 | Adenylate kinase 2, mitochondrial | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 15 |
B8128 | | AK3, AK3L1, AK6 | GTP:AMP phosphotransferase mitochondrial | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B8129 | | AK3L1, AK3L2, AK3 | Adenylate kinase isoenzyme 4, mitochondrial | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 14 |
B8130 | | AK5 | Adenylate kinase 5 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B8131 | | AK7 | Putative adenylate kinase 7 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 5 |
B8132 | | AK8 | Putative Adenylate kinase-like protein C9ORF98 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 4 |
B8133 | | AK9, AKD1, AKD2 | Adenylate kinase domain containing 1 | Blood | RRMS_(CD8+), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0510 | | AKAP1, AKAP149, PRKA1 | A kinase anchor protein 1, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0506 | | AKAP10 | A kinase anchor protein 10, mitochondrial precursor | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0507 | | AKAP11, AKAP220 | A-kinase anchor protein 11 | Blood | MS (Multiple sclerosis) | 1 |
B0508 | | AKAP12, AKAP250 | A-kinase anchor protein 12 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0529 | | AKAP13, BRX, HT31 | A-kinase anchoring protein 13 | Blood | RRMS_(CD4+), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 22 |
B0497 | | AKAP17A, SFRS17A, XE7 | Splicing factor, arginine/serine-rich 17A | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0511 | | AKAP2, PRKA2, PALM2-AKAP2 | A-kinase anchor protein 2 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B0512 | | AKAP3, AKAP110, SOB1 | A-kinase anchor protein 3 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0513 | | AKAP4, AKAP82 | A-kinase anchor protein 4 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B0514 | | AKAP5, AKAP79 | A-kinase anchor protein 5 | Blood | MS (Multiple sclerosis) | 1 |
B0515 | | AKAP6, AKAP100 | A-kinase anchor protein 6 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
BK022 | | AKAP7, AKAP18, AKAP15 | Protein kinase A anchoring protein 7 isoform gamma | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0516 | | AKAP8, AKAP95 | A-kinase anchor protein 8 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0530 | | AKAP8L, NAKAP95, HAP95 | A-kinase anchor protein 8-like | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 7 |
B0517 | | AKAP9, AKAP350, AKAP450 | A-kinase anchor protein 9 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0524 | | AKIP1, BCA3 | Proline-rich protein BCA3 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0525 | | AKIRIN1 | Akirin-1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0526 | | AKIRIN2 | Akirin-2 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
220530_at | | AKIRIN2-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0527 | | AKNA | AT-hook transcription factor AKNA | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0528 | | AKNAD1 | Uncharacterized protein C1ORF62 | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0498 | | AKR1A1, ALDR1, ALR | Alcohol dehydrogenase [NADP+] | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B0561 | | AKR1B1, ALDR1 | Aldose reductase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0501 | | AKR1C1, DDH, DDH1 | Aldo-keto reductase family 1 member C1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0502 | | AKR1C2, DDH2 | Aldo-keto reductase family 1 member C2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up) (Multiple sclerosis) | 1 |
B0503 | | AKR1C3, DDH1, HSD17B5 | Aldo-keto reductase family 1 member C3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0505 | | AKR1D1, SRD5B1 | 3-oxo-5-beta-steroid 4-dehydrogenase | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B0519 | | AKR1E2, AKR1CL2, AKRDC1 | 1,5-anhydro-D-fructose reductase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 4 |
B0972 | | AKR7A2, AFAR, AFAR1 | Aflatoxin B1 aldehyde reductase 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0973 | | AKR7A3, AFAR2 | Aflatoxin B1 aldehyde reductase 2 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0974 | | AKR7L, AFAR3, AKR7A4 | Aflatoxin B1 aldehyde reductase 3 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0531 | | AKT1, PKB, RAC | RAC-alpha serine/threonine kinase | Blood | MS (Multiple sclerosis) | 1 |
B0534 | | AKT1S1, PRAS40 | Proline-rich AKT1 substrate 1 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
BJ412 | | AKT2 | RAC-beta serine/threonine protein kinase | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0532 | | AKT3, PKBG | RAC-gamma serine/threonine protein kinase | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 13 |
B0533 | | AKTIP, FTS | Fused toes homolog | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B7084 | | ALAD | Delta-aminolevulinic acid dehydratase | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B7083 | | ALAS1, ALAS3, ALASH | 5-aminolevulinic acid synthase, nonspecific, mitochondrial precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B7082 | | ALAS2, ALASE, ASB | 5-aminolevulinate synthase 2 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B5654 | | Alb, FBF1, ALB | Fas-binding factor 1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0556 | | ALB, GIG20, GIG42 | Serum albumin precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B2381 | | ALCAM, MEMD | CD166 antigen precursor | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0153 | | ALD, ABCD1, ALDP | Adrenoleukodystrophy protein | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0065 | | ALDH16A1 | Aldehyde dehydrogenase 16A1 | Blood | MS (Multiple sclerosis) | 1 |
BB751 | | ALDH18A1, GSAS, P5CS | Delta 1-pyrroline-5-carboxylate synthetase | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0536 | | ALDH1A1, ALDC, ALDH1 | Aldehyde dehydrogenase 1A1 | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0537 | | ALDH1A2, RALDH2, RALDH2-T | Retinal dehydrogenase 2 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0538 | | ALDH1A3, ALDH6 | Aldehyde dehydrogenase 6 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0539 | | ALDH1B1, ALDH5, ALDHX | Aldehyde dehydrogenase X, mitochondrial | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0540 | | ALDH1L1, FTHFD | Aldehyde dehydrogenase 1 family, member L1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B0541 | | ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Blood | CIS (Multiple sclerosis) | 1 |
B0557 | | ALDH2, ALDM | Aldehyde dehydrogenase, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0546 | | ALDH3A2, ALDH10, FALDH | Fatty aldehyde dehydrogenase | Blood | MS (Multiple sclerosis) | 2 |
B0547 | | ALDH3B1, ALDH7 | Aldehyde dehydrogenase 7 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0548 | | ALDH3B2, ALDH8 | Aldehyde dehydrogenase 8 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 2 |
B0549 | | ALDH4A1, ALDH4, P5CDH | Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BF634 | | ALDH5A1, SSADH | Succinate semialdehyde dehydrogenase, mitochondrial precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0551 | | ALDH7A1, ATQ1 | Aldehyde dehydrogenase family 7 member A1 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 8 |
B0552 | | ALDH8A1, ALDH12 | Aldehyde dehydrogenase 12 | Blood | PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 1 |
B0553 | | ALDH9A1, ALDH4, ALDH7 | Aldehyde dehydrogenase 9A1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0558 | | ALDOA, ALDA | Fructose-bisphosphate aldolase A | Blood | MS (Multiple sclerosis) | 3 |
211617_at | | ALDOAP2 | unspecified molecule w/o gene mapping | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 1 |
B0559 | | ALDOB, ALDB | Fructose-bisphosphate aldolase B | Blood | CIS, RRMS_(CD4+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 10 |
B0560 | | ALDOC, ALDC | Fructose-bisphosphate aldolase C | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0562 | | ALG1, HMAT1, HMT1 | Chitobiosyldiphosphodolichol beta-mannosyltransferase | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0439 | | ALG10, ALG10A | Alpha2-glucosyltransferase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0440 | | ALG10B, KCR1 | Putative Alpha-1,2-glucosyltransferase ALG10-B | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0564 | | ALG12, PP14673, PP3999 | Dolichyl-p-Man:Man(7)GlcNAc(2)-PP-dolichyl mannosyltransferase | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0565 | | ALG13, GLT28D1, MDS031 | Asparagine-liked glycosylation 13 homolog | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0566 | | ALG14 | UDP-N-acetylglucosamine transferase subunit ALG14 homolog | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0568 | | ALG2, UNQ666/PRO1298, UNQ666 | Alpha-1,3-mannosyltransferase ALG2 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0569 | | ALG3, NOT, NOT56L | Alpha-1,3-mannosyltransferase ALG3 | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B0570 | | ALG5, HSPC149 | Dolichyl-phosphate beta-glucosyltransferase | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0571 | | ALG6, My046 | Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase | Blood | MS (Multiple sclerosis) | 1 |
B0572 | | ALG8, HUSSY-02 | Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3- glucosyltransferase | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 2 |
B0573 | | ALG9, DIBD1 | Alpha-1,2-mannosyltransferase ALG9 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B0574 | | ALK | ALK tyrosine kinase receptor | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0575 | | ALKBH1, ABH, ABH1 | Alkylated DNA repair protein alkB homolog 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0576 | | ALKBH2, ABH2 | Alpha-ketoglutarate-dependent dioxygenase ALKB homolog 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0577 | | ALKBH3, ABH3, DEPC1 | Alpha-ketoglutarate-dependent dioxygenase ALKB homolog 3 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0578 | | ALKBH4, ABH4 | Alkylated DNA repair protein ALKB homolog 4 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0579 | | ALKBH5, ABH5, OFOXD1 | Alkylated DNA repair protein ALKB homolog 5 | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0580 | | ALKBH6, ABH6 | 2Og-Fe(II) oxygenase domain containing protein | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0581 | | ALKBH7, ABH7, SPATA11 | Alkylated DNA repair protein ALKB homolog 7 precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 13 |
B0582 | | ALKBH8, ABH8 | Alkylated DNA repair protein alkB homolog 8 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
B0584 | | ALLC | Probable allantoicase | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0586 | | ALMS1 | Alstrom syndrome protein 1 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0585 | | ALMS1P, ALMS1L | Putative ALMS1-like protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B8985 | | ALOX12, LOG12, 12LO | Arachidonate 12-lipoxygenase, 12S-type | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B9192 | | ALOX12B | Arachidonate 12-lipoxygenase, 12R type | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1A23 | | ALOX12P2 | Similar to Arachidonate 12-lipoxygenase, epidermal-type | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B8986 | | ALOX15, LOG15 | Arachidonate 15-lipoxygenase | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B9193 | | ALOX15B | Arachidonate 15-lipoxygenase B | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
BJ692 | | ALOX5, LOG5 | Arachidonate 5-lipoxygenase | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0550 | | ALOX5AP, FLAP | Arachidonate 5-lipoxygenase-activating protein | Blood | RRMS_SPMS (Multiple sclerosis) | 3 |
B8987 | | ALOXE3 | Epidermis-type lipoxygenase 3 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
BC685 | | ALPI | Alkaline phosphatase, intestinal precursor | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
B0587 | | ALPK1, LAK | Alpha-protein kinase 1 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0588 | | ALPK2, HAK | Alpha-protein kinase 2 | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 1 |
BC687 | | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme precursor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BC684 | | ALPP, PLAP | Alkaline phosphatase, placental type 1 precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
BC686 | | ALPPL2, ALPPL | Alkaline phosphatase, placental-like precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0590 | | ALR, GFER, HERV1 | FAD-linked sulfhydryl oxidase ALR | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0592 | | ALS2, ALS2CR6 | Alsin | Blood | RRMS_SPMS (Multiple sclerosis) | 5 |
B0542 | | ALS2CL | ALS2 C-terminal-like protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0543 | | ALS2CR11 | Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein | Blood | CIS, RRMS_(High_Sema4A) (Multiple sclerosis) | 2 |
B0544 | | ALS2CR12 | Amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 12 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BG712 | | ALS2CR4, TMEM237 | Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1967 | | ALS2CR8, CARF, NYD-SP24 | Amyotrophic lateral sclerosis 2 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 4 |
B0594 | | ALX3 | Homeobox protein aristaless-like 3 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 1 |
B0595 | | ALX4 | Homeobox protein aristaless-like 4 | Blood | CIS (Multiple sclerosis) | 1 |
BG495 | | ALYREF, ALY, BEF | THO complex subunit 4 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0596 | | AMACR | Alpha-methylacyl-CoA racemase | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0597 | | AMBN | Ameloblastin precursor | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 3 |
B0598 | | AMBP, ITIL, HCP | AMBP protein precursor | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0627 | | AMBRA1 | Activating molecule in BECN1-regulated autophagy protein 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B4147 | | AMD1, AMD | Adenosylmethionine decarboxylase 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
BA302 | | AMDHD2, CGI-14 | Putative N-acetylglucosamine-6-phosphate deacetylase | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(High_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 14 |
B0602 | | AMER1, FAM123B, WTX | APC membrane recruitment protein 1 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0603 | | AMER2, FAM123A | APC membrane recruitment protein 2 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0604 | | AMER3, FAM123C | APC membrane recruitment protein 3 | Blood | RRMS_(High_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0606 | | AMFR, RNF45 | E3 ubiquitin-protein ligase AMFR | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B9749 | | AMH, MIF | Muellerian-inhibiting factor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B0610 | | AMHR2, AMHR, MISR2 | Anti-Mullerian hormone type II receptor precursor | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
B7986 | | AMICA1, JAML, UNQ722/PRO1387 | Junctional adhesion molecule-like precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0607 | | AMIGO1, ALI2, AMIGO | Amphoterin-induced protein 1 precursor | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 4 |
B0608 | | AMIGO2, ALI1, ALI 1 | Amphoterin-induced protein 2 precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0609 | | AMIGO3, ALI3, UNQ6084/PRO20089 | Amphoterin-induced gene and ORF 3 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
BE232 | | AML2, RUNX3, CBFA3 | RUNT-related transcription factor 3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0611 | | AMMECR1 | AMME syndrome candidate gene 1 protein | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0605 | | AMMECR1L | AMMECR1-like protein | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0613 | | AMN, UNQ513, UNQ513/PRO1028 | Protein amnionless | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
B0612 | | AMN1 | Protein AMN1 homolog | Blood | MS (Multiple sclerosis) | 1 |
B0616 | | AMOT | Angiomotin | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0614 | | AMOTL1 | Angiomotin-like protein 1 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0615 | | AMOTL2 | Angiomotin-like protein 2 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0619 | | AMPD2 | AMP deaminase 2 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0620 | | AMPD3 | Adenosine monophosphate deaminase 3 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0622 | | AMPH, AMPH1 | Amphiphysin I | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B6304 | | AMT, GCST | Aminomethyltransferase, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0629 | | AMY1B, AMY1A, AMY1 | Alpha-amylase 1B, salivary precursor | Blood | RRMS_SPMS, PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0630 | | AMY2B | Alpha-amylase 2B precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0632 | | AMZ1 | Archaemetzincin 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up) (Multiple sclerosis) | 2 |
B0633 | | AMZ2, BM-014 | Archaemetzincin-2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up) (Multiple sclerosis) | 1 |
BU151 | | AMZ2P1 | Hypothetical protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0825 | | ANAPC1, TSG24 | Anaphase promoting complex subunit 1 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0826 | | ANAPC10, APC10 | Anaphase promoting complex subunit 10 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0827 | | ANAPC11, HSPC214 | Anaphase promoting complex subunit 11 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0828 | | ANAPC13 | Anaphase-promotingcomplex subunit 13 | Blood | RRMS_(CD8+), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0829 | | ANAPC15, HSPC020 | Uncharacterized protein C11ORF51 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0830 | | ANAPC16 | UPF0448 protein C10ORF104 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B0653 | | ANAPC2, APC2 | Anaphase promoting complex subunit 2 | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B0832 | | ANAPC4, APC4 | Anaphase promoting complex subunit 4 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0833 | | ANAPC5, APC5, PDL-108 | Anaphase promoting complex subunit 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0834 | | ANAPC7, APC7 | Anaphase promoting complex subunit 7 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0661 | | ANG, RNASE5, HEL168 | Angiogenin precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0659 | | ANGEL1 | Angel homolog 1 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
B0660 | | ANGEL2 | ANGEL2 protein | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0669 | | ANGPT1, AngA | Angiopoietin-1 precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0670 | | ANGPT2, angiopoietin-2B, AGPT2 | Angiopoietin-2 precursor | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0671 | | ANGPT4, ANG3, ANG4 | Angiopoietin-4 precursor | Blood | CIS, RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 3 |
B0662 | | ANGPTL1, ANG3, ANGPT3 | Angiopoietin-like 1 | Blood | CIS, RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0663 | | ANGPTL2, ARP2, UNQ170/PRO196 | Angiopoietin-related protein 2 precursor | Blood | CIS, RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B0664 | | ANGPTL3, ANGPT5, UNQ153/PRO179 | Angiopoietin-related protein 3 precursor | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0665 | | ANGPTL4, ARP4, HFARP | Angiopoietin-related protein 4 precursor | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
B0666 | | ANGPTL5, UNQ5795, UNQ5795/PRO19600 | Angiopoietin-related protein 5 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0667 | | ANGPTL6, AGF, ARP5 | Angiopoietin-related protein 6 precursor | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0668 | | ANGPTL7, CDT6, UNQ313/PRO356 | Angiopoietin-related protein 7 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0673 | | ANHX | Anomalous homeobox protein | Blood | RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0675 | | ANK2 | Ankyrin 2 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0676 | | ANK3 | Ankyrin 3 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 3 |
B0677 | | ANKAR | Ankyrin and armadillo repeat-containing protein | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0520 | | ANKDD1A | Ankyrin repeat and death domain-containing protein 1A | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 5 |
B0678 | | ANKEF1, ANKRD5 | Ankyrin repeat domain protein 5 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0679 | | ANKFN1 | Ankyrin repeat and fibronectin type-III domain-containing protein 1 | Blood | CIS, RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 6 |
B0658 | | ANKFY1, ANKHZN | Ankyrin repeats- and FYVE domain-containing protein 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B0680 | | ANKH, UNQ241/PRO274, UNQ241 | Progressive ankylosis protein homolog | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0681 | | ANKHD1, MASK | Ankyrin repeat and KH domain-containing protein 1 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0522 | | ANKIB1 | Ankyrin repeat and IBR domain containing 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0683 | | ANKLE1, ANKRD41, LEM3 | Ankyrin repeat and LEM domain-containing protein 1 | Blood | RRMS_(CD4+), RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0684 | | ANKLE2, LEM4 | Ankyrin repeat and LEM domain-containing protein 2 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0694 | | ANKMY2 | Ankyrin repeat and MYND domain-containing protein 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0751 | | ANKRA2, ANKRA | Ankyrin-repeat family A protein 2 | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0685 | | ANKRD1, CARP, HA1A2 | Ankyrin repeat domain-containing protein 1 | Blood | CIS, RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0717 | | ANKRD10 | Ankyrin repeat domain protein 10 | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0718 | | ANKRD11, MU-MB-20.240, LZ16 | Ankyrin repeat domain-containing protein 11 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 24 |
B0719 | | ANKRD12, ANCO2, GAC-1 | Ankyrin repeat domain-containing protein 12 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0634 | | ANKRD13, ANKRD13A, NY-REN-25 | Ankyrin repeat domain-containing protein 13A | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0635 | | ANKRD13B | Ankyrin repeat domain-containing protein 13B | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 2 |
B0636 | | ANKRD13C | Ankyrin repeat domain-containing protein 13C | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0637 | | ANKRD13D | Ankyrin repeat domain 13 family, member D | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0720 | | ANKRD16 | Ankyrin repeat domain-containing protein 16 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0721 | | ANKRD17, GTAR, NY-BR-16 | Ankyrin repeat domain protein 17 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 8 |
B0638 | | ANKRD18A | Ankyrin repeat domain protein 18A | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0639 | | ANKRD18B | Ankyrin repeat domain-containing protein 18B | Blood | RRMS_(CD4+), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 4 |
BJ251 | | ANKRD19P, ANKRD19 | Ankyrin repeat domain-containing protein 19 | Blood | MS (Multiple sclerosis) | 1 |
B0686 | | ANKRD2, ARPP | Ankyrin repeat domain protein 2 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0074 | | ANKRD20A1, ANKRD20A | Ankyrin repeat domain-containing protein 20A1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 6 |
BK330 | | ANKRD20A11P | Hypothetical C21orf81 protein | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
A_24_P187056 | | ANKRD20A12P | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
A_32_P109604 | | ANKRD20A12P | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0075 | | ANKRD20A2 | Ankyrin repeat domain-containing protein 20A2 | Blood | RRMS_SPMS (Multiple sclerosis) | 5 |
B0076 | | ANKRD20A3 | Ankyrin repeat domain-containing protein 20A3 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0078 | | ANKRD20A5P, ANKRD20A5 | Ankyrin repeat domain 20 family, member A5 | Blood | RRMS_SPMS (Multiple sclerosis) | 4 |
B3F70 | | ANKRD20A9P | Putative uncharacterized protein ENSP00000397428 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 6 |
B0640 | | ANKRD20B, ANKRD20A8P | Ankyrin repeat domain-containing protein 20B | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0722 | | ANKRD22 | Ankyrin repeat domain-containing protein 22 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 22 |
B0723 | | ANKRD23, DARP | Ankyrin repeat domain-containing protein 23 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, CIS, RRMS_(CD4+) (Multiple sclerosis) | 6 |
B0725 | | ANKRD26 | Ankyrin repeat domain-containing protein 26 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0726 | | ANKRD27, PP12899 | Ankyrin repeat domain-containing protein 27 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0727 | | ANKRD28 | Ankyrin repeat domain-containing protein 28 | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0728 | | ANKRD29 | Ankyrin repeat domain-containing protein 29 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0641 | | ANKRD30A, NY-BR-1, CTSP1 | Ankyrin repeat domain 30A | Blood | CIS (Multiple sclerosis) | 1 |
B0642 | | ANKRD30B, NY-BR-1.1 | Breast cancer antigen NY-BR-1.1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+) (Multiple sclerosis) | 3 |
1561225_at | | ANKRD30BP3 | unspecified molecule w/o gene mapping | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
1570474_s_at | | ANKRD30BP3 | unspecified molecule w/o gene mapping | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0730 | | ANKRD32, BRCTD1 | Ankyrin repeat domain-containing protein 32 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0731 | | ANKRD33 | Ankyrin repeat domain-containing protein 33 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0647 | | ANKRD33B | Ankyrin repeat domain-containing protein 33B | Blood | CIS, RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 5 |
B0648 | | ANKRD34A, ANKRD34 | Ankyrin repeat domain-containing protein 34A | Blood | CIS, RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 3 |
B0650 | | ANKRD34C | Ankyrin repeat domain-containing protein 34C | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B0732 | | ANKRD35 | Ankyrin repeat domain-containing protein 35 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
BJ416 | | ANKRD36, ANKRD36A, UNQ2430/PRO499 | Ankyrin repeat domain 36 | Blood | RRMS_(Low_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
BJ417 | | ANKRD36B | Ankyrin repeat domain 36B | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
BJ250 | | ANKRD36BP1, ANKRD26L1 | Ankyrin repeat domain-containing protein 26-like 1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1I99 | | ANKRD36BP2 | Conserved hypothetical protein | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 11 |
B0651 | | ANKRD36C | Protein immuno-reactive with anti-PTH polyclonal antibodies | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 7 |
B0733 | | ANKRD37, LPR2BP, LRP2BP | Low density lipoprotein receptor-related protein 2-binding protein | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0734 | | ANKRD39, HSPC200 | Ankyrin repeat domain-containing protein 39 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 4 |
B0735 | | ANKRD40 | Ankyrin repeat domain-containing protein 40 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 3 |
B0736 | | ANKRD42 | Ankyrin repeat domain-containing protein 42 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0737 | | ANKRD44 | Ankyrin repeat domain-containing protein 44 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0739 | | ANKRD46 | Ankyrin repeat containing protein 46 | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0740 | | ANKRD49, FGIF | Ankyrin repeat domain-containing protein 49 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0741 | | ANKRD50 | Ankyrin repeat domain-containing protein 50 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 5 |
BJ419 | | ANKRD52 | Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0742 | | ANKRD53 | Ankyrin repeat domain-containing protein 53 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0743 | | ANKRD54, LIAR | Ankyrin repeat domain-containing protein 54 | Blood | RRMS_SPMS (Multiple sclerosis) | 3 |
B0744 | | ANKRD55 | Ankyrin repeat domain-containing protein 55 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0687 | | ANKRD6 | Ankyrin repeat domain-containing protein 6 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0745 | | ANKRD60 | Ankyrin repeat domain-containing protein 60 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B0749 | | ANKRD65 | Hypothetical protein LOC441869 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0688 | | ANKRD7 | Ankyrin repeat domain protein 7 | Blood | CIS, RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 4 |
B0689 | | ANKRD9 | Ankyrin repeat domain-containing protein 9 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 2 |
B0753 | | ANKS1A, ANKS1, ODIN | Ankyrin repeat and SAM domain containing protein 1A | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0754 | | ANKS1B, EB-1 | Cajalin 2 | Blood | CIS (Multiple sclerosis) | 1 |
B0690 | | ANKS3 | Ankyrin repeat and SAM domain-containing protein 3 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B0755 | | ANKS4B, HARP | Ankyrin repeat and SAM domain-containing protein 4B | Blood | CIS (Multiple sclerosis) | 1 |
B0691 | | ANKS6, ANKRD14, SAMD6 | Ankyrin repeat and SAM domain-containing protein 6 | Blood | CIS, RRMS_SPMS, RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0692 | | ANKUB1 | Hypothetical protein | Blood | RRMS_(High_Sema4A), RRMS_(CD4+) (Multiple sclerosis) | 2 |
B0695 | | ANKZF1, ZNF744 | Ankyrin repeat and zinc finger domain-containing protein 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0696 | | ANLN | Actin-binding protein Anillin | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0704 | | ANO1, DOG1, ORAOV2 | Anoctamin-1 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B0705 | | ANO10, TMEM16K | Anoctamin-10 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0706 | | ANO2, TMEM16B | Anoctamin-2 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B0708 | | ANO4, TMEM16D | Anoctamin-4 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 2 |
B0709 | | ANO5, GDD1, TMEM16E | Anoctamin-5 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0710 | | ANO6, TMEM16F | Anoctamin 6 | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 5 |
B0711 | | ANO7, NGEP, PCANAP5 | Anoctamin-7 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0712 | | ANO8, TMEM16H | Anoctamin-8 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0713 | | ANO9, PIG5, TMEM16J | Tumor protein P53 inducible protein 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(CD8+) (Multiple sclerosis) | 5 |
BJ415 | | ANP32A, LANP, MAPM | Acidic leucine-rich nuclear phosphoprotein 32 family member A | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
BK315 | | ANP32A-IT1 | Hypothetical protein | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0643 | | ANP32B, APRIL, PHAPI2 | Acidic leucine-rich nuclear phosphoprotein 32 family member B | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0644 | | ANP32C, PP32R1 | Acidic leucine-rich nuclear phosphoprotein 32 family member C | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0646 | | ANP32E | Acidic (leucine-rich) nuclear phosphoprotein 32 family member E | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0757 | | ANTXR1, ATR, TEM8 | Anthrax toxin receptor 1 precursor | Blood | RRMS_(CD4+), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 5 |
B0758 | | ANTXR2, CMG2 | Anthrax toxin receptor 2 | Blood | CIS, RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 14 |
B0763 | | ANXA1, ANX1, LPC1 | Annexin A1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
B0761 | | ANXA11, ANX11 | Annexin A11 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0762 | | ANXA13, ANX13 | Annexin A13 | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0764 | | ANXA2, ANX2, ANX2L4 | Annexin A2 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 11 |
BL071 | | ANXA2P1 | OK/SW-CL.79 protein | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
A_24_P323114 | | ANXA2P3 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1300 | | ANXA2R, AX2R | Annexin-2 receptor | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0765 | | ANXA3, ANX3 | Annexin A3 | Blood | RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0766 | | ANXA4, PIG28, ANX4 | Annexin A4 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 11 |
B0767 | | ANXA5, ANX5, ENX2 | Annexin A5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0768 | | ANXA6, ANX6 | Annexin A6 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0769 | | ANXA7, ANX7, SNX | Annexin A7 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0770 | | ANXA8L1, ANXA8, ANX8 | Annexin A8 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
BO306 | | ANXA8L2-locus | Hypothetical protein | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0771 | | ANXA9, ANX31 | Annexin A9 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 2 |
B0772 | | AOAH | Acyloxyacyl hydrolase precursor | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0775 | | AOC3, VAP1 | Membrane copper amine oxidase | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
216601_at | | AOC4P | unspecified molecule w/o gene mapping | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
A_24_P781615 | | AOC4P | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0625 | | AOPEP, ONPEP | Aminopeptidase O | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0780 | | AP1AR, PRO0971 | Gamma-1-adaptin Brefeldin A resistance protein | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0781 | | AP1B1, ADTB1, BAM22 | AP-1 complex subunit beta-1 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0782 | | AP1G1, ADTG, CLAPG1 | Adapter-related protein complex 1 gamma 1 subunit | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B0783 | | AP1G2 | Adapter-related protein complex 1 gamma 2 subunit | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0784 | | AP1M1, CLTNM | Adaptor-related protein complex 1, mu 1 subunit | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0785 | | AP1M2 | Adaptor-related protein complex 1, mu 2 subunit | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 3 |
B0786 | | AP1S1, AP19, CLAPS1 | Adapter-related protein complex 1 sigma 1A subunit | Blood | RRMS_(CD8+) (Multiple sclerosis) | 2 |
B0787 | | AP1S2, DC22 | Adapter-related protein complex 1 sigma 1B subunit | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 14 |
B0788 | | AP1S3 | Adapter-related protein complex 1 sigma 1C subunit | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0790 | | AP2A1, ADTAA, CLAPA1 | Adapter-related protein complex 2 alpha 1 subunit | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0791 | | AP2A2, ADTAB, CLAPA2 | Adapter-related protein complex 2 alpha 2 subunit | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0793 | | AP2B1, ADTB2, CLAPB1 | Adapter-related protein complex 2 beta 1 subunit | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0797 | | AP2M1, CLAPM1 | AP-2 complex subunit mu | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0798 | | AP2S1, AP17, CLAPS2 | AP-2 complex subunit sigma | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B0799 | | AP3B1, ADTB3A | Adapter-related protein complex 3 beta 1 subunit | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0800 | | AP3B2 | Adapter-related protein complex 3 beta 2 subunit | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B0801 | | AP3D1, PRO0039 | Adapter-related protein complex 3 delta 1 subunit | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0802 | | AP3M1 | Adapter-related protein complex 3 mu 1 subunit | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0803 | | AP3M2 | Adapter-related protein complex 3 mu 2 subunit | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0804 | | AP3S1, CLAPS3 | Adapter-related protein complex 3 sigma 1 subunit | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0805 | | AP3S2 | AP-3 complex subunit sigma-2 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0808 | | AP4B1 | Adapter-related protein complex 4 beta 1 subunit | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B0809 | | AP4E1 | Adapter-related protein complex 4 epsilon 1 subunit | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B0810 | | AP4M1, MUARP2 | Adapter-related protein complex 4 mu 1 subunit | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0811 | | AP4S1 | Adapter-related protein complex 4 sigma 1 subunit | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 6 |
B0812 | | AP5B1, PP1030 | AP-5 complex subunit beta | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0813 | | AP5M1, MUDENG | MHD domain-containing death-inducing protein | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 2 |
B0815 | | AP5Z1, SPG48 | AP-5 complex subunit zeta-1 | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0816 | | APAF1 | Apoptotic protease activating factor 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0817 | | APBA1, MINT1, X11 | Amyloid beta A4 precursor protein-binding family A member 1 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0818 | | APBA2, MINT2, X11L | Amyloid beta A4 precursor protein-binding family A member 2 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
B0820 | | APBB1, FE65, RIR | Amyloid beta A4 precursor protein-binding family B member 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0123 | | APBB1IP, PREL1, RARP1 | Amyloid beta A4 protein-binding, family B, member 1 interacting protein | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0821 | | APBB2, FE65L, FE65L1 | Amyloid beta A4 precursor protein-binding family B member 2 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 8 |
B0822 | | APBB3, FE65L2, Fe65L2 | Amyloid beta A4 precursor protein-binding family B member 3 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0824 | | APC, DP2.5 | Adenomatous polyposis coli protein | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B0831 | | APC2, APCL | Adenomatous polyposis coli protein 2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0835 | | APCDD1, DRAPC1, FP7019 | Adenomatosis polyposis coli down-regulated 1 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0836 | | APCDD1L | Similar to alpha 4 collagen IV | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
BE542 | | APCS, PTX2 | Serum amyloid P-component precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0277 | | APEH, D3F15S2, D3S48E | Acylamino-acid-releasing enzyme | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
1559280_a_at | | APELA | unspecified molecule w/o gene mapping | Blood | CIS, RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B0837 | | APEX1, APE, APEX | DNA-(apurinic or apyrimidinic site) lyase | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0838 | | APEX2, APE2, APEXL2 | DNA-(apurinic or apyrimidinic site) lyase 2 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0839 | | APH1A, PSF, CGI-78 | Gamma-secretase subunit APH-1A | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0840 | | APH-1b, APH1B, PSFL | Gamma-secretase subunit APH-1B | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0841 | | API5, MIG8, AAC11 | Apoptosis inhibitor 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
BA101 | | APIP, CGI-29, MMRP19 | Methylthioribulose-1-phosphate dehydratase | Blood | MS (Multiple sclerosis) | 1 |
B2621 | | APITD1, CENPS, FAAP16 | Centromere protein S | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
BJ420 | | APLN, APEL | Apelin precursor | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0842 | | APLNR, AGTRL1, APJ | Apelin receptor | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B0845 | | APLP1 | Amyloid-like protein 1 precursor | Blood | CIS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B0846 | | APLP2, APPL2, HSD-2 | Amyloid-like protein 2 precursor | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 11 |
B0847 | | APMAP, UNQ1869/PRO4305, UNQ1869 | Adipocyte plasma membrane-associated protein | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0848 | | APOA, LPA | Apolipoprotein(A) precursor | Blood | CIS, RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0849 | | APOA1, A175P | Apolipoprotein A-I precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BA732 | | APOA1BP, AIBP, YJEFN1 | Apolipoprotein A-I binding protein | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0850 | | APOA2 | Apolipoprotein A-II precursor | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B0852 | | APOA5, RAP3, UNQ411/PRO773 | Apolipoprotein A-V | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0853 | | APOB | Apolipoprotein B-100 precursor | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0166 | | APOBEC1 | Apolipoprotein B mRNA editing enzyme | Blood | CIS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B0124 | | APOBEC3A | Probable C->U editing enzyme APOBEC-3A | Blood | CIS, RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 11 |
B0125 | | APOBEC3B, APOBEC1L | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B0126 | | APOBEC3C, APOBEC1L, PBI | Probable DNA DC->DU-editing enzyme APOBEC-3C | Blood | RRMS_(High_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0128 | | APOBEC3F, bK150C2.4 | DNA DC->DU editing enzyme APOBEC-3F | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0129 | | APOBEC3G, MDS019 | DNA dC->dU-editing enzyme APOBEC-3G | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0130 | | APOBEC3H, APOBEC1L, ARP10 | Apolipoprotein B mRNA editing protein and Phorbolin 1 like | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B0168 | | APOBEC4 | Putative C->U-editing enzyme APOBEC-4 | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 1 |
B0854 | | APOBR, APOB48R | Apolipoprotein B receptor | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0855 | | APOC1, APOC1B | Apolipoprotein C-I precursor | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0856 | | APOC2, APC2 | Apolipoprotein C-II precursor | Blood | RRMS_(Low_Sema4A), CIS, RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 6 |
B0857 | | APOC3 | Apolipoprotein C-III precursor | Blood | CIS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B0858 | | APOC4 | Apolipoprotein C-IV precursor | Blood | RRMS_(CD4+) (Multiple sclerosis) | 1 |
B0859 | | APOD | Apolipoprotein D precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0860 | | APOE | Apolipoprotein E precursor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0862 | | APOH, B2G1 | Beta-2-glycoprotein 1 precursor | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 3 |
B0863 | | APOL1, APOL | Apolipoprotein L1 precursor | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0864 | | APOL2 | Apolipoprotein-L2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0865 | | APOL3 | Apolipoprotein L3 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B0866 | | APOL4 | Apolipoprotein L4 precursor | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B0868 | | APOL6, UNQ3095/PRO21341, ApoL6 | Apolipoprotein L6 | Blood | CIS, RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 25 |
B0843 | | APOLD1, VERGE | Apolipoprotein L domain-containing protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B0869 | | APOM, G3A, NG20 | Apolipoprotein M | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0870 | | APOO, FAM121B, My025 | Apolipoprotein O precursor | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0871 | | APOOL, FAM121A, UNQ8193/PRO23204 | Putative uncharacterized protein APOOL | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 9 |
B0872 | | APOPT1, APOP1, KLC1 | Similar to RIKEN cDNA 2810002N01 gene | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0084 | | APP, A4, AD1 | Amyloid beta A4 protein | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0823 | | APPBP2, PAT1 | Amyloid protein-binding protein 2 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B4548 | | APPL1, APPL, DIP13A | Adaptor protein APPL | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0874 | | APRG1 | AP20 region protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0877 | | APRT | Adenine phosphoribosyltransferase | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
A_32_P61605 | | APTR | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0878 | | APTX, AXA1 | Forkhead-associated domain histidine-triad like protein | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0881 | | AQP1, CHIP28 | Aquaporin 1 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0882 | | AQP10 | Aquaporin 10 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0879 | | AQP12A, AQP12, AQPX2 | Aquaporin-12A | Blood | MS (Multiple sclerosis) | 1 |
B0884 | | AQP2 | Aquaporin-CD | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0885 | | AQP3 | Aquaporin 3 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B0886 | | AQP4 | Aquaporin 4 | Blood | CIS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
BK320 | | AQP4-AS1 | Hypothetical protein FLJ30507 | Blood | CIS (Multiple sclerosis) | 1 |
B0887 | | AQP5 | Aquaporin 5 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0888 | | AQP6, AQP2L | Aquaporin 6 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 2 |
BJ421 | | AQP7, AQP7L, AQP9 | Aquaporin 7 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0890 | | AQP8 | Aquaporin 8 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0891 | | AQP9, SSC1 | Aquaporin-9 | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0892 | | AQR | Aquarius | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 5 |
B0654 | | AR, NR3C4, DHTR | Androgen receptor | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0900 | | ARAF, ARAF1, PKS | A-Raf proto-oncogene serine/threonine-protein kinase | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0902 | | ARAP1, CENTD2 | Centaurin delta 2 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0903 | | ARAP2, CENTD1 | Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0904 | | ARAP3, CENTD3 | Centaurin-delta-3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B3391 | | ARCN1, COPD | Coatomer delta subunit | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BF046 | | AREC3, SIX4 | Homeobox protein SIX4 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 1 |
B0912 | | AREG, SDGF, AREGB | Amphiregulin precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0913 | | AREL1 | Similar to ubiquitin-ligase | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0914 | | ARF1 | ADP-ribosylation factor 1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0915 | | ARF3 | ADP-ribosylation factor 3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0916 | | ARF4, ARF2 | ADP-ribosylation factor 4 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0917 | | ARF5 | ADP-ribosylation factor 5 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0918 | | ARF6 | ADP-ribosylation factor 6 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0919 | | ARFGAP1, ARF1GAP | ADP-ribosylation factor GTPase activating protein 1 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0920 | | ARFGAP2, ZNF289 | ADP-ribosylation factor GTPase-activating protein 2 | Blood | MS, RRMS_SPMS, CIS, RRMS_(High_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0921 | | ARFGAP3, ARFGAP1 | ADP-ribosylation factor GTPase-activating protein 3 | Blood | PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 1 |
B1504 | | ARFGEF1, ARFGEP1, BIG1 | Brefeldin A-inhibited guanine nucleotide-exchange protein 1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1505 | | ARFGEF2, ARFGEP2, BIG2 | Brefeldin A-inhibited guanine nucleotide-exchange protein 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0922 | | ARFIP1 | Arfaptin 1 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 6 |
B0923 | | ARFIP2, POR1 | Arfaptin 2 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B0924 | | ARFRP1, ARP1 | ARF-related protein | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0931 | | ARG1 | Arginase 1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B0932 | | ARG2 | Arginase-2, mitochondrial precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0933 | | ARGLU1 | Arginine and glutamate-rich protein 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
BD669 | | ARHGAP1, CDC42GAP, RHOGAP1 | Rho-GTPase-activating protein 1 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BD676 | | ARHGAP10, GRAF2, GRAF-2 | Graf2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 3 |
BD701 | | ARHGAP11A | RHO GTPase activating protein 11A | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BD677 | | ARHGAP12 | Rho-GTPase-activating protein 12 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BD678 | | ARHGAP15, BM-024, BM-030 | RHO GTPase-activating protein 15 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BJ838 | | ARHGAP17, RICH1, MSTP066 | RHO GTPase-activating protein 17 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BD680 | | ARHGAP19, ARHGAP19-SLIT1 | RHO GTPase-activating protein 19 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
BD681 | | ARHGAP20 | RHO GTPase-activating protein 20 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
BD682 | | ARHGAP21, ARHGAP10 | RHO GTPase activating protein 21 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
BD683 | | ARHGAP22, RHOGAP2, RhoGAP2 | Rho GTPase activating protein 22 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
1556460_a_at | | ARHGAP22-IT1 | unspecified molecule w/o gene mapping | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
BD684 | | ARHGAP23 | RHO GTPase activating protein 23 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
BD685 | | ARHGAP24, FILGAP, NY-SAR-88 | RHO GTPase-activating protein 24 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 11 |
BD686 | | ARHGAP25 | Rho GTPase activating protein 25 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
BD687 | | ARHGAP26, GRAF, OPHN1L | RHO GTPase-activating protein 26 | Blood | RRMS_(CD4+), RRMS_(CD8+), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
BD690 | | ARHGAP29, PARG1 | RHO GTPase-activating protein 29 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
BD691 | | ARHGAP30 | Rho GTPase-activating protein 30 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
BD692 | | ARHGAP31, CDGAP | Rho GTPase-activating protein 31 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BD693 | | ARHGAP32, RICS, GRIT | Rho/CDC42/Rac GTPase-activating protein RICS | Blood | CIS, RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
BD694 | | ARHGAP33, SNX26, TCGAP | Sorting nexin 26 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BD695 | | ARHGAP35, GRF1, GRLF1 | Glucocorticoid receptor DNA binding factor 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 12 |
BD670 | | ARHGAP4, C1, RGC1 | Rho-GTPase-activating protein 4 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
BD699 | | ARHGAP42 | Rho GTPase-activating protein 42 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BD700 | | ARHGAP44, RICH2, NPC-A-10 | RHO GTPase-activating protein RICH2 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BD671 | | ARHGAP5, RHOGAP5 | Rho-GTPase-activating protein 5 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B0905 | | ARHGAP5-AS1 | Putative uncharacterized protein ARHGAP5-AS1 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 4 |
BD672 | | ARHGAP6, RHOGAP6 | Rho-GTPase-activating protein 6 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BD674 | | ARHGAP8, BPGAP1, PRR5-ARHGAP8 | Rho GTPase-activating protein 8 | Blood | CIS, PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 3 |
BD675 | | ARHGAP9, RGL1, HSPC076 | Rho-GTPase-activating protein 9 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B6327 | | ARHGDIA, GDIA1 | Rho GDP-dissociation inhibitor 1 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B6328 | | ARHGDIB, GDIA2, GDID4 | Rho GDP-dissociation inhibitor 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 7 |
B6329 | | ARHGDIG | Rho GDP-dissociation inhibitor 3 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0938 | | ARHGEF1 | Rho guanine nucleotide exchange factor 1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0947 | | ARHGEF10 | Rho guanine nucleotide exchange factor 10 | Blood | RRMS_(High_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 18 |
B0929 | | ARHGEF10L, GRINCHGEF | Rho guanine nucleotide exchange factor (GEF) 10-like | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B0948 | | ARHGEF11 | Rho guanine nucleotide exchange factor 11 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BJ422 | | ARHGEF12, LARG | Rho guanine nucleotide exchange factor 12 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B0949 | | ARHGEF15 | Rho guanine nucleotide exchange factor 15 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0950 | | ARHGEF16, EPHEXIN4, NBR | Rho guanine exchange factor (GEF) 16 | Blood | CIS, RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0951 | | ARHGEF17, TEM4 | RHO guanine nucleotide exchange factor 17 | Blood | CIS, PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0952 | | ARHGEF18, P114-RHO-GEF | Rho guanine nucleotide exchange factor 18 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
B0953 | | ARHGEF19 | Rho guanine nucleotide exchange factor 19 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0939 | | ARHGEF2, LFP40 | Guanine nucleotide exchange factor GEF-H1 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0954 | | ARHGEF25, GEFT, SLC26A10 | Guanine nucleotide exchange factor GEFT | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0955 | | ARHGEF26, SGEF, HMFN1864 | Rho guanine nucleotide exchange factor 26 | Blood | CIS, MS, RRMS_SPMS (Multiple sclerosis) | 4 |
236575_at | | ARHGEF26-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B0925 | | ARHGEF28, RGNEF | RHO-Guanine nucleotide exchange factor | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 4 |
B0940 | | ARHGEF3 | Rho guanine nucleotide exchange factor 3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
228596_at | | ARHGEF34P | unspecified molecule w/o gene mapping | Blood | MS (Multiple sclerosis) | 1 |
B0927 | | ARHGEF35, ARHGEF5L | Rho guanine nucleotide exchange factor 35 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0935 | | ARHGEF37 | Probable Guanine nucleotide exchange factor FLJ41603 | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0936 | | ARHGEF38 | Putative RHO guanine nucleotide exchange factor FLJ20184 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0928 | | ARHGEF39 | DH domain containing protein | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
B0941 | | ARHGEF4, ASEF | Rho guanine nucleotide exchange factor 4 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0937 | | ARHGEF40, SOLO | Rho guanine nucleotide exchange factor 40 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0942 | | ARHGEF5, TIM | Rho guanine nucleotide exchange factor 5 | Blood | CIS, MS, RRMS_SPMS (Multiple sclerosis) | 5 |
B0943 | | ARHGEF6, COOL2, PIXA | Rho guanine nucleotide exchange factor 6 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B0944 | | ARHGEF7, COOL1, P85SPR | Rho guanine nucleotide exchange factor 7 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
1560510_at | | ARHGEF7-IT1 | unspecified molecule w/o gene mapping | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up) (Multiple sclerosis) | 1 |
B0946 | | ARHGEF9, ARHDH9 | RHO guanine nucleotide exchange factor 9 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B4805 | | ARIA, ECSCR, ECSM2 | Endothelial cell-specific chemotaxis regulator | Blood | CIS, RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0959 | | ARID1A, BAF250, BAF250A | AT-rich interactive domain-containing protein 1A | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B0960 | | ARID1B, BAF250B, DAN15 | AT-rich interactive domain-containing protein 1B | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0970 | | ARID2 | AT-rich interactive domain-containing protein 2 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0963 | | ARID3A, DRIL1, DRIL3 | Dead ringer like-1 protein | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0964 | | ARID3B, BDP, DRIL2 | Bright and dead ringer gene product homologous protein Bdp | Blood | RRMS_(High_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B0966 | | ARID4A, RBBP1, RBP1 | Retinoblastoma-binding protein 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B0967 | | ARID4B, BRCAA1, RBBP1L1 | SIN3A-associated protein 180 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0968 | | ARID5A, MRF1, MRF-1 | Modulator recognition factor I | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0969 | | ARID5B, DESRT, MRF2 | AT-rich interactive domain-containing protein 5B | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 15 |
B0958 | | ARIH1, ARI, MOP6 | Ariadne-1 protein homolog | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0961 | | ARIH2, ARI2, TRIAD1 | Ariadne-2 protein homolog | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 14 |
B0962 | | ARIH2OS | Uncharacterized protein ARIH2OS | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B3610 | | ARKL1 | Uncharacterized protein C18orf25 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B0975 | | ARL1 | ADP-ribosylation factor-like protein 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B0976 | | ARL10, ARL10A | ADP-ribosylation factor-like protein 10 | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B0977 | | ARL11, ARLTS1 | ADP-ribosylation factor-like protein 11 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B0893 | | ARL13A | ADP-ribosylation factor-like 13 | Blood | MS (Multiple sclerosis) | 1 |
B0894 | | ARL13B, ARL2L1 | ADP-ribosylation factor-like protein 13B | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B0978 | | ARL14, ARF7 | ADP-ribosylation factor-like protein 14 | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B0535 | | ARL14EP, ARF7EP | Similar to D.melanogaster protein CG14464 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0979 | | ARL15, ARFRP2 | ARFRP2 protein | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 2 |
B0980 | | ARL16 | ADP-ribosylation factor-like protein 16 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
B0981 | | ARL17A, ARL17P1, ARL17B | ADP-ribosylation factor-like protein 17 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 15 |
B0982 | | ARL2, SNX15 | ADP-ribosylation factor-like protein 2 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B0896 | | ARL2BP, BART, BART1 | ARF-like 2 binding protein BART1 | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 3 |
B0983 | | ARL3, ARFL3 | ADP-ribosylation factor-like protein 3 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0984 | | ARL4A, ARL4 | ADP-ribosylation factor-like protein 4 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0986 | | ARL4D, ARF4L | ADP-ribosylation factor-like protein 4L | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 3 |
B0987 | | ARL5A, ARFLP5, ARL5 | ADP-ribosylation factor-like protein 5A | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0988 | | ARL5B, ARL8 | ADP-ribosylation factor-like protein 8 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B0990 | | ARL6, BBS3 | ADP-ribosylation factor-like protein 6 | Blood | MS (Multiple sclerosis) | 1 |
B0897 | | ARL6IP1, ARL6IP | ADP-ribosylation factor-like protein 6-interacting protein 1 | Blood | MS (Multiple sclerosis) | 1 |
B0898 | | ARL6IP4 | ADP-ribosylation-like factor 6 interacting protein 4 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BC791 | | ARL6IP5, DERP11, JWA | Vitamin A responsive, cytoskeleton related | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B0899 | | ARL6IP6, PFAAP1 | ADP-ribosylation factor-like protein 6-interacting protein 6 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 5 |
B0985 | | ARL7, ARL4C | ADP-ribosylation factor-like protein 7 | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B0991 | | ARL8A, ARL10B, GIE2 | ADP-ribosylation factor-like protein 8A | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0992 | | ARL8B, ARL10C, GIE1 | ADP-ribosylation factor-like protein 8B | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B0997 | | ARMC1, ARCP | Armadillo repeat-containing protein 1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B0995 | | ARMC10, SVH | Armadillo repeat-containing protein 10 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0998 | | ARMC2 | Armadillo repeat containing protein 2 | Blood | CIS (Multiple sclerosis) | 1 |
B1000 | | ARMC4 | Armadillo repeat-containing protein 4 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1001 | | ARMC5 | Armadillo repeat-containing protein 5 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1003 | | ARMC7 | Armadillo repeat-containing protein 7 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1004 | | ARMC8, S863-2, HSPC056 | Armadillo repeat containing protein 8 | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 13 |
BJ423 | | ARMC9 | ARM protein ARMC9 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1006 | | ARMCX1, ALEX1, AD032 | Armadillo repeat-containing X-linked protein 1 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1007 | | ARMCX2, ALEX2 | Armadillo repeat protein ALEX2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B1008 | | ARMCX3, ALEX3, BM-017 | Armadillo repeat-containing X-linked protein 3 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1009 | | ARMCX4 | Armadillo repeat-containing X-linked protein 4 | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B1010 | | ARMCX5 | Armadillo repeat-containing X-linked protein 5 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1011 | | ARMCX6 | Armadillo repeat containing, X-linked 6 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B1012 | | ARNT, BHLHE2 | Aryl hydrocarbon receptor nuclear translocator | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B1013 | | ARNT2, BHLHE1 | Aryl hydrocarbon receptor nuclear translocator 2 | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1534 | | ARNTL, BHLHE5, BMAL1 | Aryl hydrocarbon receptor nuclear translocator-like protein 1 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
B1535 | | ARNTL2, BHLHE6, BMAL2 | Aryl hydrocarbon receptor nuclear translocator-like protein 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B0909 | | ARPC1A, SOP2L | Actin-related protein 2/3 complex subunit 1A | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B0910 | | ARPC1B, ARC41 | ARP2/3 complex 41 kDa subunit | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1025 | | ARPC2, ARC34, PRO2446 | ARP2/3 complex 34 kDa subunit | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 4 |
B1026 | | ARPC3, ARC21 | ARP2/3 complex 21 kDa subunit | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1027 | | ARPC4, ARC20, ARPC4-TTLL3 | Actin-related protein 2/3 complex subunit 4 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1028 | | ARPC5, ARC16 | ARP2/3 complex 16 kDa subunit | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B1022 | | ARPC5L, ARC16-2 | Actin-related protein 2/3 complex subunit 5-like protein | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B1029 | | ARPIN | UPF0552 protein C15orf38 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1016 | | ARPP19, ARPP-19 | cAMP-regulated phosphoprotein 19 | Blood | CIS, RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 15 |
B1018 | | ARPP21, ARPP-21, TARPP | cAMP-regulated phosphoprotein 21 | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 7 |
B1032 | | ARR3, ARRX, CAR | Arrestin-C | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1030 | | ARRB1, ARR1 | Beta-arrestin 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 28 |
B1031 | | ARRB2, ARB2, ARR2 | Beta-arrestin 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B1033 | | ARRDC1 | Arrestin domain containing 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B2841 | | ARRDC1-AS1 | Hypothetical protein | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1034 | | ARRDC2, PP2703 | Arrestin domain-containing protein 2 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 2 |
B1035 | | ARRDC3 | Arrestin domain-containing protein 3 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
239395_at | | ARRDC3-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(CD8+) (Multiple sclerosis) | 1 |
B1036 | | ARRDC4 | Arrestin domain-containing protein 4 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1037 | | ARRDC5 | Arresin domain containing 5 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1040 | | ARSB | Arylsulfatase B precursor | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 12 |
B1041 | | ARSD | Arylsulfatase D precursor | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B1042 | | ARSE | Arylsulfatase E precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1043 | | ARSF | Arylsulfatase F precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B1044 | | ARSG, UNQ839/PRO1777, UNQ839 | Arylsulfatase G precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1048 | | ARSK, TSULF, UNQ630/PRO1246 | Arylsulfatase K | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
BA339 | | ART1 | GPI-linked NAD(P(+)--arginine ADP-ribosyltransferase 1 precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 2 |
BA340 | | ART3, TMART | Ecto-ADP-ribosyltransferase 3 precursor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
BA341 | | ART4, DO, DOK1 | Ecto-ADP-ribosyltransferase 4 precursor | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 1 |
BA342 | | ART5, UNQ575, UNQ575/PRO1137 | Ecto-ADP-ribosyltransferase 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up) (Multiple sclerosis) | 1 |
B1049 | | ARTN, EVN | Neurotrophic factor artemin | Blood | CIS, RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1050 | | ARV1, HT035 | Cell cycle-related protein | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1051 | | ARVCF | Armadillo repeat protein deleted in velo-cardio-facial syndrome | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1052 | | ARX | Homeobox protein ARX | Blood | CIS, RRMS_SPMS (Multiple sclerosis) | 2 |
B1055 | | AS3MT, CYT19 | Arsenite methyltransferase | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1058 | | ASAH1, ASAH, HSD33 | Acid ceramidase precursor | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1056 | | ASAH2B, ASAH2L | Putative inactive neutral ceramidase B | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1060 | | ASAP1, DDEF1 | 130-kDa phosphatidylinositol 4,5-biphosphate-dependent ARF1 GTPase- activating protein | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 7 |
1557685_at | | ASAP1-IT2 | unspecified molecule w/o gene mapping | Blood | RRMS_(High_Sema4A), PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 3 |
A_24_P162128 | | ASAP1-IT2 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1061 | | ASAP2, DDEF2 | Development and differentiation-enhancing factor 2 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1062 | | ASAP3, DDEFL1, UPLC1 | ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 1 |
B1064 | | ASB1 | Ankyrin repeat and SOCS box containing protein 1 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B1066 | | ASB11 | Ankyrin repeat and SOCS box containing protein 11 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B1067 | | ASB12 | Ankyrin repeat and SOCS box containing protein 12 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up) (Multiple sclerosis) | 1 |
B1068 | | ASB13 | Ankyrin repeat and SOCS box containing protein 13 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1069 | | ASB14 | Ankyrin repeat and SOCS box containing protein 14 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 3 |
B1070 | | ASB15 | Ankyrin repeat and SOCS box protein 15 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B1071 | | ASB16 | Ankyrin repeat and SOCS box protein 16 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1063 | | ASB16-AS1 | Putative uncharacterized protein ASB16-AS1 | Blood | MS (Multiple sclerosis) | 1 |
B1072 | | ASB17 | Ankyrin repeat and SOCS box containing protein 17 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B1073 | | ASB18 | SOCS box protein ASB-18 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 4 |
B1074 | | ASB2 | Ankyrin repeat and SOCS box containing protein 2 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1075 | | ASB3, GPR75-ASB3 | Ankyrin repeat and SOCS box containing protein 3 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1076 | | ASB4 | Ankyrin repeat and SOCS box containing protein 4 | Blood | CIS, RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B1077 | | ASB5 | Ankyrin repeat and SOCS box containing protein 5 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 1 |
B1078 | | ASB6 | Ankyrin repeat and SOCS box containing protein 6 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1079 | | ASB7 | Ankyrin repeat and SOCS box containing protein 7 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B1080 | | ASB8, PP14212 | Ankyrin repeat and SOCS box containing protein 8 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1081 | | ASB9 | Ankyrin repeat and SOCS box containing protein 9 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1083 | | ASCC1, CGI-18 | Activating signal cointegrator 1 complex subunit 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 3 |
B1084 | | ASCC2, ASC1P100, ASC1p100 | Activating signal cointegrator 1 complex subunit 2 | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1085 | | ASCC3, HELIC1, RNAH | Activating signal cointegrator 1 complex subunit 3 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1086 | | ASCL1, ASH1, BHLHA46 | Achaete-scute homolog 1 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1087 | | ASCL2, BHLHA45, HASH2 | Achaete-scute homolog 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, CIS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1090 | | ASCL5, BHLHA47 | Achaete-Scute homolog 5 | Blood | CIS (Multiple sclerosis) | 1 |
B1091 | | ASF1A, CGI-98, HSPC146 | Histone chaperone ASF1A | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1092 | | ASF1B, CIA-II | Histone chaperone ASF1B | Blood | RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1094 | | ASGR1, CLEC4H1 | Asialoglycoprotein receptor 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
B1095 | | ASGR2, HBXBP, CLEC4H2 | Asialoglycoprotein receptor 2 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1096 | | ASH1L, KMT2H | Absent, small, or homeotic 1-like | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
1554057_at | | ASH1L-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
A_24_P272225 | | ASH1L-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1097 | | ASH2L, ASH2L1 | SET1/ASH2 histone methyltransferase complex subunit ASH2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1103 | | ASIC5, ACCN5, HINAC | Amiloride-sensitive cation channel 5, intestinal | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 2 |
B1104 | | ASIP, AGTI, AGTIL | Agouti switch protein precursor | Blood | RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
B0994 | | ASL, LP3236 | Argininosuccinate lyase | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 3 |
B1109 | | ASMT, ASMTX, ASMTY | Hydroxyindole O-methyltransferase | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 2 |
B1108 | | ASMTL, ASMTLX, ASMTLY | N-acetylserotonin O-methyltransferase-like protein | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1110 | | ASNA1, ARSA, TRC40 | Arsenical pump-driving ATPase | Blood | RRMS_SPMS (Multiple sclerosis) | 3 |
B1112 | | ASNS, TS11 | Asparagine synthetase [glutamine-hydrolyzing] | Blood | CIS, RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 5 |
B1111 | | ASNSD1, NS3TP1 | Asparagine synthetase domain-containing protein 1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B0323 | | ASPA, ACY2, ASP | Aspartoacylase | Blood | RRMS_(CD4+), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
B1114 | | ASPDH | Putative L-aspartate dehydrogenase | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1116 | | ASPH | Junctin | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B1117 | | ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B1118 | | ASPHD2, ASPHL | Aspartate beta-hydroxylase domain-containing protein 2 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1119 | | ASPM, MCPH5 | Abnormal spindles | Blood | CIS, RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1120 | | ASPN, PLAP1, UNQ215 | Asporin | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 3 |
B0876 | | ASPRV1, SASP | Retroviral-like aspartic protease 1 precursor | Blood | RRMS_(High_Sema4A), RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(Low_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1113 | | ASPSCR1, ASPL, RCC17 | Alveolar soft part sarcoma chromosome region, candidate 1 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B1093 | | ASRGL1, ALP, CRASH | L-Asparaginase | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1124 | | ASS1, ASS | Argininosuccinate synthase | Blood | CIS, RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1125 | | ASTE1, HT001 | Asteroid homolog 1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1128 | | ASTN1, ASTN | Astrotactin 1 | Blood | RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B1129 | | ASTN2 | Astrotactin2 | Blood | RRMS_(Low_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1130 | | ASUN, NY-SAR-95, PNAS-25 | Cell cycle regulator MAT89BB homolog | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1131 | | ASXL1, ASXH1 | Putative Polycomb group protein ASXL1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 14 |
B1132 | | ASXL2, ASXH2 | Polycomb group protein | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1133 | | ASXL3 | Putative Polycomb group protein ASXL3 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 2 |
B1134 | | ASZ1, ALP1, ANKL1 | Germ cell-specific ankyrin, SAM and basic leucine zipper domain containing protein | Blood | CIS, MS (Multiple sclerosis) | 2 |
B0756 | | AT3, SERPINC1, PRO0309 | Antithrombin-III precursor | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
194 | | AT3G04710 | unspecified molecule w/o gene mapping | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B1178 | | ATAD1 | ATPase family AAA domain-containing protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1179 | | ATAD2, L16, PRO2000 | ATPase family AAA domain containing protein 2 | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1183 | | ATAD2B | ATPase family AAA domain-containing protein 2B | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1184 | | ATAD3A | ATPase family, AAA domain containing, protein 3A | Blood | RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 4 |
B1185 | | ATAD3B, TOB3 | ATPase family AAA domain-containing protein 3B | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1186 | | ATAD3C | ATPase family AAA domain-containing protein 3C | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 1 |
BC765 | | ATAD4, PRR15L | ATPase family AAA domain-containing protein 4 | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
B1180 | | ATAD5, FRAG1 | ATPase family, AAA domain containing 5 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1181 | | ATAT1, MEC17 | UPF0635 protein C6ORF134 | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1182 | | ATCAY | Caytaxin | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1187 | | ATE1 | Arginyl-tRNA-protein transferase 1 | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
BH722 | | ATF, PLAU | Urokinase-type plasminogen activator precursor | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B1188 | | ATF1 | Cyclic-AMP-dependent transcription factor ATF-1 | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1189 | | ATF2, CREB2, CREBP1 | Cyclic-AMP-dependent transcription factor ATF-2 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1190 | | ATF3, ATF3deltaZip2exonD'DE'E, ATF3deltaZip2a | Cyclic-AMP-dependent transcription factor ATF-3 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1191 | | ATF4, CREB2, TXREB | Cyclic-AMP-dependent transcription factor ATF-4 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1192 | | ATF5, ATFX | Cyclic-AMP-dependent transcription factor ATF-5 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1193 | | ATF6 | Cyclic-AMP-dependent transcription factor ATF-6 alpha | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B1194 | | ATF6B, CREBL1, G13 | Cyclic-AMP-dependent transcription factor ATF-6 beta | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 5 |
B1195 | | ATF7, ATFA | Cyclic-AMP-dependent transcription factor ATF-7 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 13 |
B9486 | | ATF7IP, MCAF, MCAF1 | Activating transcription factor 7-interacting protein 1 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B9487 | | ATF7IP2, MCAF2 | Activating transcription factor 7 interacting protein 2 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1196 | | ATG10, PP12616, APG10L | Ubiquitin-like-conjugating enzyme ATG10 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B1210 | | ATG101, PP894 | Autophagy-related protein 101 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1197 | | ATG12, APG12, APG12L | Autophagy-related protein 12 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1198 | | ATG13 | Autophagy-related protein 13 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1388 | | ATG14 | Hypothetical protein | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 3 |
B0066 | | ATG16L1, APG16L, UNQ9393/PRO34307 | Autophagy protein 16-like | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 4 |
B0067 | | ATG16L2, WDR80 | Autophagy-related protein 16-2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1199 | | ATG2A | Autophagy-related protein 2 homolog A | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1200 | | ATG2B | Autophagy-related protein 2 homolog B | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1201 | | ATG3, APG3, APG3L | Autophagy-related protein 3 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1202 | | ATG4A, APG4A, AUTL2 | Apg4A | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1203 | | ATG4B, HAPG4B, AUTL1 | Cysteine protease ATG4B | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1204 | | ATG4C, APG4C, AUTL1 | Cysteine protease ATG4C | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1205 | | ATG4D, APG4D, AUTL4 | Cysteine protease ATG4D | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1206 | | ATG5, APG5L, ASP | Autophagy protein 5-like | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1207 | | ATG7, APG7L, GSA7 | Autophagy-related protein 7 | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B1208 | | ATG9A, APG9L1 | Autophagy-related protein 9A | Blood | RRMS_(Low_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1209 | | ATG9B, APG9L2, NOS3AS | Autophagy-related protein 9b | Blood | RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 1 |
B0468 | | ATGR2, AGTR2 | Type-2 angiotensin II receptor | Blood | RRMS_(CD8+), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B1211 | | ATHL1 | Acid trehalase-like protein 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up) (Multiple sclerosis) | 2 |
BD140 | | ATIC, PURH | Bifunctional purine biosynthesis protein PURH | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1218 | | ATL1, SPG3A, GBP3 | Atlastin | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1219 | | ATL2, ARL6IP2 | Atlastin-2 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 8 |
B1220 | | ATL3 | Atlastin-3 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
B1221 | | ATM | Serine-protein kinase ATM | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B1222 | | ATMIN, ZNF822, ASCIZ | ATM/ATR-substrate CHK2-interacting Zn2+-finger protein | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1223 | | ATN1, D12S755E, DRPLA | Atrophin-1 | Blood | CIS, RRMS_(CD4+), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B1225 | | ATOH1, ATH1, BHLHA14 | Atonal protein homolog 1 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B1226 | | ATOH7, ATH5, BHLHA13 | Atonal homolog 7 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1227 | | ATOH8, ATH6, BHLHA21 | Atonal homolog 8 | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 4 |
B1228 | | ATOX1, HAH1 | Copper transport protein ATOX1 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1135 | | ATP10A, ATP10C, ATPVA | ATPase, class V, type 10A | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1136 | | ATP10B, ATPVB | Potential phospholipid-transporting ATPase VB | Blood | RRMS_(High_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1137 | | ATP10D, ATPVD | Probable phospholipid-transporting ATPase VD | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1138 | | ATP11A, ATPIH, ATPIS | Potential phospholipid-transporting ATPase IH | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
1561699_a_at | | ATP11A-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+) (Multiple sclerosis) | 2 |
B1139 | | ATP11B, ATPIF, ATPIR | Potential phospholipid-transporting ATPase IF | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B1140 | | ATP11C, ATPIG, ATPIQ | Potential phospholipid-transporting ATPase IG | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1141 | | ATP12A, ATP1AL1 | Potassium-transporting ATPase alpha chain 2 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B1142 | | ATP13A1, ATP13A, CGI-152 | Probable cation-transporting ATPase 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 5 |
B1143 | | ATP13A2, PARK9, HSA9947 | Probable cation-transporting ATPase 13A2 | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1144 | | ATP13A3, AFURS1 | Probable cation-transporting ATPase 3 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B1145 | | ATP13A4, UNQ3052/PRO9871, UNQ3052 | Probable cation-transporting ATPase 13A4 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
231512_at | | ATP13A4-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 2 |
BJ425 | | ATP1A1 | Sodium/potassium-transporting ATPase alpha-1 chain precursor | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 2 |
B1249 | | ATP1A1OS | Putative uncharacterized protein ATP1A1OS | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1147 | | ATP1A2 | Sodium/potassium-transporting ATPase alpha-2 chain precursor | Blood | RRMS_(CD8+), RRMS_SPMS (Multiple sclerosis) | 2 |
B1148 | | ATP1A3 | Sodium/potassium-transporting ATPase alpha-3 chain | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |
B1149 | | ATP1A4, ATP1AL2 | Sodium/potassium-transporting ATPase alpha-4 chain | Blood | RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B1150 | | ATP1B1, ATP1B | Sodium/potassium-transporting ATPase beta-1 chain | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1151 | | ATP1B2 | Sodium/potassium-transporting ATPase beta-2 chain | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1152 | | ATP1B3 | Sodium/potassium-transporting ATPase beta-3 chain | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up) (Multiple sclerosis) | 3 |
B0Z60 | | ATP1B3P1 | Na,K-ATPase beta-3 subunit pseudogene | Blood | RRMS_(IFN-Beta-1a_6_month_follow-up) (Multiple sclerosis) | 1 |
B1153 | | ATP1B4 | X/potassium-transporting ATPase beta-m chain | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 1 |
B1154 | | ATP2A1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1155 | | ATP2A2, ATP2B | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1156 | | ATP2A3 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Blood | RRMS_(High_Sema4A), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
B1157 | | ATP2B1, PMCA1 | Plasma membrane calcium-transporting ATPase 1 | Blood | RRMS_(High_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1158 | | ATP2B2, PMCA2, PMCA2I | Plasma membrane calcium-transporting ATPase 2 | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 4 |
A_32_P132194 | | ATP2B2-IT2 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
BJ426 | | ATP2B3, PMCA3A | Plasma membrane calcium-transporting ATPase 3 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1159 | | ATP2B4, MXRA1 | Plasma membrane calcium-transporting ATPase 4 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 12 |
B1160 | | ATP2C1, PMR1L, HUSSY-28 | Calcium-transporting ATPase type 2C, member 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1161 | | ATP2C2, SPCA2 | Calcium-transporting ATPase type 2C member 2 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1231 | | ATP4B | Potassium-transporting ATPase beta chain | Blood | CIS (Multiple sclerosis) | 1 |
B1166 | | ATP5A, ATP5G2 | ATP synthase lipid-binding protein, mitochondrial precursor | Blood | RRMS_(High_Sema4A), RRMS_SPMS (Multiple sclerosis) | 3 |
B1242 | | ATP5A1, ATP5A, ATP5AL2 | ATP synthase alpha chain, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(Low_Sema4A), RRMS_(CD4+), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1243 | | ATP5B, ATPMB, ATPSB | ATP synthase beta chain, mitochondrial precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B1246 | | ATP5C1, ATP5C, ATP5CL1 | ATP synthase gamma chain, mitochondrial precursor | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
B1244 | | ATP5D | ATP synthase delta chain, mitochondrial precursor | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1232 | | ATP5E | ATP synthase epsilon chain, mitochondrial | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B1164 | | ATP5F1 | ATP synthase B chain, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B1165 | | ATP5G1 | ATP synthase lipid-binding protein, mitochondrial precursor | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
217368_at | | ATP5G2P1 | unspecified molecule w/o gene mapping | Blood | PPMS_(PRF1_gene_Risk_haplotype) (Multiple sclerosis) | 2 |
B1167 | | ATP5G3 | ATP synthase lipid-binding protein, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
B1233 | | ATP5H, My032 | ATP synthase D chain, mitochondrial | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BJ429 | | ATP5I, ATP5K | ATP synthase e chain, mitochondrial | Blood | MS (Multiple sclerosis) | 1 |
B1234 | | ATP5J, ATP5A, ATPM | ATP synthase coupling factor 6, mitochondrial precursor | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1247 | | ATP5J2, ATP5JL, ATP5J2-PTCD1 | ATP synthase f chain, mitochondrial | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_SPMS (Multiple sclerosis) | 8 |
B1235 | | ATP5L | ATP synthase G chain, mitochondrial | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 16 |
B1248 | | ATP5O, ATPO | ATP synthase subunit O, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1236 | | ATP5S, ATPW | ATP synthase subunit s, mitochondrial | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B1169 | | ATP5SL | ATP synthase subunit S-like protein | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
BH780 | | ATP6AP1, ATP6IP1, ATP6S1 | V-type proton ATPase subunit S1 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BH781 | | ATP6AP1L | V-type proton ATPase subunit S1-like protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
BD530 | | ATP6AP2, ATP6IP2, CAPER | Renin receptor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
BH801 | | ATP6C, ATP6V0C, ATP6L | Vacuolar ATP synthase 16 kDa proteolipid subunit | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
BH901 | | ATP6V0A1, ATP6N1, ATP6N1A | Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1 | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BH902 | | ATP6V0A2, TJ6 | Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2 | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 9 |
BH904 | | ATP6V0A4, ATP6N1B, ATP6N2 | Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BH802 | | ATP6V0B, ATP6F | Vacuolar ATP synthase 21 kDa proteolipid subunit | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
A_24_P118326 | | ATP6V0CP3 | unspecified molecule w/o gene mapping | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
BH764 | | ATP6V0D1, ATP6D, VPATPD | Vacuolar ATP synthase subunit D 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
BH765 | | ATP6V0D2 | Vacuolar proton pump subunit D 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BH766 | | ATP6V0E, ATP6V0E1, ATP6H | V-type proton ATPase subunit E 1 | Blood | RRMS_(High_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 11 |
BH767 | | ATP6V0E2, ATP6V0E2L | V-type proton ATPase subunit E 2 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 2 |
229094_at | | ATP6V0E2-AS1 | unspecified molecule w/o gene mapping | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 4 |
B1V91 | | ATP6V0E2-AS1 | LOC401431 protein | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
BH788 | | ATP6V1A, ATP6A1, ATP6V1A1 | Vacuolar ATP synthase catalytic subunit A, ubiquitous isoform | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 5 |
BH789 | | ATP6V1B1, ATP6B1, VATB | V-type proton ATPase subunit B, kidney isoform | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
BH790 | | ATP6V1B2, ATP6B2, VPP3 | Vacuolar ATP synthase subunit B, brain isoform | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
BH791 | | ATP6V1C1, ATP6C, ATP6D | Vacuolar ATP synthase subunit C 1 | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 18 |
BH793 | | ATP6V1D, VATD, ATP6M | Vacuolar ATP synthase subunit D | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
BH794 | | ATP6V1E1, ATP6E, ATP6E2 | Vacuolar ATP synthase subunit E | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
BH795 | | ATP6V1E2, ATP6E1, ATP6EL2 | V-type proton ATPase subunit E 2 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 2 |
BH796 | | ATP6V1F, ATP6S14, VATF | V-type proton ATPase subunit F | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
BH797 | | ATP6V1G1, ATP6G, ATP6G1 | Vacuolar ATP synthase subunit G 1 | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
BH798 | | ATP6V1G2, ATP6G, ATP6G2 | Vacuolar ATP synthase subunit G 2 | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
BH799 | | ATP6V1G3, ATP6G3 | Vacuolar ATP synthase subunit G 3 | Blood | MS (Multiple sclerosis) | 1 |
BH800 | | ATP6V1H, CGI-11, MSTP042 | V-type proton ATPase subunit H | Blood | MS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1238 | | ATP7A, MC1, MNK | Copper-transporting ATPase 1 | Blood | MS, RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1239 | | ATP7B, PWD, WC1 | Copper-transporting ATPase 2 | Blood | CIS, RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B1173 | | ATP8A1, ATPIA | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | Blood | RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1174 | | ATP8A2, ATPIB | Potential phospholipid-transporting ATPase IB | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 3 |
B1175 | | ATP8B1, ATPIC, FIC1 | Potential phospholipid-transporting ATPase IC | Blood | RRMS_(rIFN-Beta-1b_24_month_follow-up) (Multiple sclerosis) | 1 |
B1176 | | ATP8B2, ATPID | Potential phospholipid-transporting ATPase ID | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
BJ428 | | ATP8B3, ATP1K, FOS37502_2 | Potential phospholipid-transporting ATPase IK | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1177 | | ATP8B4 | Potential phospholipid-transporting ATPase IM | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B0Z46 | | ATP8B5P | ATPase, class I, type 8B family pseudogene | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1241 | | ATP9A, ATPIIA | Potential phospholipid-transporting ATPase IIA | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 7 |
BJ430 | | ATP9B, ATPIIB, NEO1L | ATPase, class II, type 9B | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 11 |
BJ431 | | ATPAF1, ATP11 | ATP synthase mitochondrial F1 complex assembly factor 1 precursor | Blood | RRMS_SPMS (Multiple sclerosis) | 2 |
B1245 | | ATPAF2, ATP12, LP3663 | ATP synthase mitochondrial F1 complex assembly factor 2 | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B1212 | | ATPIF1, ATPI, ASI | ATPase inhibitor, mitochondrial precursor | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B1250 | | ATR, FRP1 | Serine-protein kinase ATR | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 6 |
B0901 | | ATRAID, Apr-03, HSPC013 | Apoptosis related protein APR-3 | Blood | RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up) (Multiple sclerosis) | 2 |
B1252 | | ATRIP, AGS1 | ATR-interacting protein | Blood | RRMS_(CD8+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 11 |
BJ432 | | ATRN, MGCA | Attractin precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 4 |
B1253 | | ATRNL1 | Attractin-like protein 1 | Blood | RRMS_(Low_Sema4A), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1254 | | ATRX, RAD54L, XH2 | Transcriptional regulator ATRX | Blood | RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 10 |
B1275 | | ATXN1, ATX1, SCA1 | Ataxin-1 | Blood | RRMS_(Low_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 11 |
B1276 | | ATXN10, SCA10, E46L | Ataxin-10 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 4 |
B1277 | | ATXN1L, BOAT, BOAT1 | Ataxin-1-like | Blood | RRMS_(High_Sema4A), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 5 |
B1278 | | ATXN2, ATX2, SCA2 | Ataxin-2 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1279 | | ATXN2L, A2D, A2LG | Ataxin-2-like protein | Blood | RRMS_(Low_Sema4A), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 6 |
B1280 | | ATXN3, MJD, MJD1 | Ataxin-3 | Blood | RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 17 |
B1281 | | ATXN3L, ATX3L, MJDL | Putative Ataxin-3-like protein | Blood | RRMS_(CD4+), RRMS_(CD8+) (Multiple sclerosis) | 2 |
B1170 | | ATXN7L1, ATXN7L4 | Ataxin-7-like protein 1 | Blood | PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 6 |
B1171 | | ATXN7L2 | Ataxin 7-like 2 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 2 |
B1172 | | ATXN7L3 | Ataxin-7-like protein 3 | Blood | RRMS_(rIFN-Beta-1b_2_days_follow-up) (Multiple sclerosis) | 1 |
B0088 | | ATXN7L3B | Hypothetical protein LOC552889 | Blood | RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
216404_at | | ATXN8OS | unspecified molecule w/o gene mapping | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up) (Multiple sclerosis) | 1 |
B1286 | | AUNIP | Aurora A-binding protein | Blood | RRMS_(CD4+), RRMS_SPMS (Multiple sclerosis) | 3 |
B1287 | | AUP1 | Ancient ubiquitous protein 1 precursor | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up) (Multiple sclerosis) | 1 |
B1288 | | AURKA, AIK, AIRK1 | Aurora kinase A | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B0523 | | AURKAIP1, AIP, AKIP | Aurora-A kinase interacting protein | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1289 | | AURKB, AIK2, AIM1 | Aurora kinase B | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 3 |
B1290 | | AURKC, AIE2, AIK3 | Serine/threonine protein kinase 13 | Blood | MS, RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
BJ433 | | AUTS2 | Autism susceptibility candidate 2 | Blood | CIS, RRMS_(High_Sema4A), RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 9 |
B1292 | | AVEN | Cell death regulator Aven | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
B1293 | | AVIL | Advillin | Blood | RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 5 |
B1294 | | AVL9 | Late secretory pathway protein AVL9 homolog | Blood | RRMS_(CD4+), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_(rIFN-Beta-1b_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 10 |
BA561 | | AVP, ARVP, VP | Vasopressin-neurophysin 2-copeptin precursor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 4 |
B1295 | | AVPI1, NPD013, PP5395 | Arginine vasopressin-induced protein 1 | Blood | RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
BH761 | | AVPR1A, AVPR1 | Vasopressin V1a receptor | Blood | RRMS_(High_Sema4A) (Multiple sclerosis) | 1 |
BH762 | | AVPR1B, AVPR3, VPR3 | Vasopressin V1b receptor | Blood | RRMS_SPMS (Multiple sclerosis) | 1 |
BH763 | | AVPR2, ADHR, DIR | Vasopressin V2 receptor | Blood | RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 2 |
B1303 | | AXDND1 | Uncharacterized protein | Blood | RRMS_(Low_Sema4A) (Multiple sclerosis) | 2 |
B1304 | | AXIN1, AXIN | Axin 1 | Blood | RRMS_(rIFN-Beta-1b_12_month_follow-up), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 3 |
B1305 | | AXIN2 | Axin 2 | Blood | RRMS_(Low_Sema4A), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS (Multiple sclerosis) | 3 |
BI454 | | AZGP1, ZAG, ZNGP1 | Zinc-alpha-2-glycoprotein precursor | Blood | RRMS_(High_Sema4A), RRMS_(Low_Sema4A), RRMS_(CD8+), RRMS_(IFN-Beta-1a_1_day_follow-up), RRMS_(IFN-Beta-1a_6_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 7 |
B1306 | | AZI1, CEP131 | 5-azacytidine-induced protein 1 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_12_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(IFN-Beta-1a_24_month_follow-up), RRMS_SPMS (Multiple sclerosis) | 8 |
B1307 | | AZI2, NAP1, TILP | 5-azacytidine-induced protein 2 | Blood | RRMS_(IFN-Beta-1b_3_month_follow-up), RRMS_(IFN-Beta-1b_24_month_follow-up), RRMS_(IFN-Beta-1a_3_month_follow-up), RRMS_(IFN-Beta-1a_12_month_follow-up), RRMS_(rIFN-Beta-1b_2_days_follow-up), RRMS_(rIFN-Beta-1b_1_month_follow-up), RRMS_(rIFN-Beta-1b_12_month_follow-up), PPMS_(PRF1_gene_Risk_haplotype), RRMS_SPMS, RRMS_(relapsing-remitting_MS) (Multiple sclerosis) | 22 |
B1308 | | AZIN1, OAZI, OAZIN | Antizyme inhibitor 1 | Blood | MS, RRMS_SPMS (Multiple sclerosis) | 3 |
B1946 | | AZU1 | Azurocidin precursor | Blood | RRMS_(IFN-Beta-1a_1_day_follow-up) (Multiple sclerosis) | 1 |